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 EXECUTIVE SUMMARY 
 
Introduction and Overview 
 
 Interest in Reproductive tract infections (RTIs) has increased enormously, and 
enthusiasm to act is palpable.  A great deal of work must be done, however, before we will be in a 
position to respond adequately to the problem.  As a result, the Population Council convened a 
meeting to examine how best to use available tools and information, learn about potential service 
delivery approaches, and examine the direction of research.  The meeting began with an 
examination of what is known about the prevalence, distribution, determinants, characteristics, 
and consequences of RTIs, as well as the common elements of an intervention framework.  The 
group then moved on to examine and discuss a range of key topics, as summarized below.  
 
 There are five basic approaches to diagnosing RTIs.  These were discussed in terms of 
their utility for diagnosing chlamydia, gonorrhea, genital ulcers, syphilis, herpes, chancroid, human 
papilloma virus (HPV), trichomoniasis, candidiasis, and bacterial vaginosis (BV).   
 
 Quantitative research conducted in Mexico, Brazil, and China was presented.  The 
Mexico study, for example, found higher levels of RTIs than expected among women in both 
hospital and community samples.  Chlamydia rates among women in the hospital sample were 
found to be as high as those found in a study of commercial sex workers in Mexico.   
 
 Qualitative research conducted in Egypt (Giza), Nigeria (Lagos), and India (Rajasthan) 
was presented.  The Rajasthan study, for example, focused on dhola Pani, the local term for white 
discharge, in an effort to develop an ethnomedical model of this problem.  Among other things, 
women believe that poverty leads to physiological weakness, which in turn results in discharge.  
Because they view the root cause of the problem as an economic one, they do not seek health 
care. 
 
 Research on the utility of algorithms and risk screening in Khon Kaen province, Thailand 
and Giza, Egypt was presented.  In both cases, the risk factors investigated were found not to 
correspond with clinical data, and, therefore, not to be predictive for RTIs.  In Giza, for example, a 
number of methods were used to determine the extent to which reports or observations of 
symptoms, compared to medical examinations, could provide an estimate of RTI prevalence.  It 
was found that the presence of discharge—regardless of who reported it and whether or not it was 
considered medically suspicious—was not predictive for RTIs.  
 
 Information presented on Vietnam and Bali, Indonesia made it clear that there is an 
urgent need to develop multi-sectoral, interdisciplinary coalitions to overcome the obstacles to 
effective RTI management.  There are, however, many obstacles to effective coalition building.  In 
order to overcome some of these obstacles, the Ford Foundation in the Philippines is supporting 
programs to bring activists from a wide range of backgrounds together to work on RTIs.   
 
 In spite of increasing consensus regarding the importance of addressing sexually 
transmitted (STDs) and merging vertical programs and services, numerous questions arise when 
it comes to investing resources in this area. Is it really necessary? Are STD programs cost-
effective? Can the impact of STD-related activities be measured? Is it feasible to implement all 
the services necessary to ensure that an STD program is effective?  Each of these questions was 
addressed based on the outcomes of related research, which, it was noted, has yet to provide 
sufficient information to overcome the skepticism.  There is an urgent need to conduct further 
research and to provide the skeptics with clear and precise information on the direct and indirect 
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consequences of RTIs, and to illustrate the possibilities for integrating RTI interventions with 
existing programs.   
 
 General obstacles related to work in the area of RTIs include lack of awareness of the 
problem and the limited power of women in society.  Obstacles to developing research include 
difficulties in setting local priorities due to lack of dialogue with or input from the community and a 
lack of alliances between researchers and service providers.  Proposals for overcoming some of 
these obstacles were presented, as were the specific obstacles confronted by RTI research 
conducted in Rajasthan, India and Kenya.  
 
 Priorities for future research and programming included: further research on the scope 
and consequences of RTIs; integration of RTI services with other types of health care; continued 
investment in female-controlled technology; research on gender and power relations and their 
relationship to STDs and related protective measures; and research on appropriate low-cost 
diagnostics and screening tools.  
 
 There was broad agreement among participants that candida, BV, and trichomonas are 
the most widespread infections.  These infections are relatively easy to deal with, but are not the 
most serious. This poses a difficult question: what does one do when the infections that are 
easiest to treat pose the least serious health problems?  There was also broad agreement that 
providers must be able to diagnose and treat RTIs in order to provide contraceptive services of an 
acceptable quality.  
 
 The group heard a great deal about the complex issues surrounding RTIs.  While more 
questions were raised than conclusions reached, the meeting helped to facilitate a move forward 
in dealing with this serious public health problem.   
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 INTRODUCTION AND OVERVIEW 
 
Beverly Winikoff  
The Population Council 
New York, New York 
 
 
 As the title of this meeting implies, we did not gather to discuss a finished product, but 
neither are we just beginning to look at the issues surrounding reproductive tract infections (RTIs). 
 These issues are so complex that we did not want to wait for the all of the research that is 
underway to be completed prior to examining the direction of our work in this area.  The timing of 
this meeting is particularly apt:  interest in RTIs is becoming widespread and enthusiasm to do 
something about the problem—and to do something soon—is palpable.  There is, however, much 
more work to be done before we will know how to respond adequately to the problem.   
 From its inception, the Population Council's Robert H. Ebert Program on Critical Issues in 
Reproductive Health and Population has been interested in the subject of RTIs and sexually 
transmitted diseases (STDs).  The Program was established in 1988 to bring attention to serious 
and understudied—and often controversial—issues affecting reproductive health.  The subject of 
RTIs is clearly relevant to the program's mandate for several reasons, including the following: 
 The problem is enormous  The World Health Organization (WHO) estimates that 100 
million acts of intercourse take place daily and that these result in the transmission of an 
estimated 356,000 sexually transmitted infections per day.   
 The problem is poorly defined  Until recently, there has been very little qualitative or 
quantitative research on the extent and dimensions of the problem.  
 The problem relates to the provision of contraceptive services  It is highly relevant to the 
Population Council and other sister institutions working in the field of family planning and repro-
ductive health.   
 The problem is controversial   Concerns aroused by discussions of RTIs, and especially 
of STDs, are emblematic of gender and power inequities, subjects which generate controversy.   
 At the same time, and more urgently, a number of different forces have focused interest 
on RTIs.  Several well-publicized studies have demonstrated that levels of infections are alarm-
ingly high, surprising both women's health advocates and the public health community.  The 
increased focus on quality of care in family planning also brought attention to RTIs, reminding us 
of issues surrounding a health care provider's ability to diagnose infections in family planning cli-
ents, appropriate use of IUDs, and the risk to a client of iatrogenic infections.  The fact that STDs 
are a known co-factor in AIDS transmission has also focused attention on the topic.  Finally, over 
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the months since the International Conference on Population and Development (ICPD) held in 
Cairo in September 1995, there has been accelerating interest in the idea of reproductive health.  
 Nonetheless, while there is strong impetus to develop strategies to deal with RTIs, there 
are great obstacles to doing so.  Related services are expensive and difficult to provide.  They 
require a range of diagnostic tests and equipment, specific and complicated training, and drugs 
that may not normally be available in a clinic setting.  In addition, clinics would have to deal with 
the complex issues of partner identification, notification, and treatment.  We also lack the techni-
cal tools for treatment, screening, and diagnosis of RTIs in resource-constrained environments.  A 
further impediment to addressing RTIs is that these services are currently orphan services.  Pro-
viders fear that existing services will be stigmatized if RTI treatment is offered alongside family 
planning services, for example, because RTIs are associated with STDs, even when they are not 
sexually transmitted.  An increased focus on RTIs can also be threatening to providers of IUDs 
and hormonal contraceptives that do not protect against sexually transmitted infections (oral 
contraceptives, NORPLANT® implants, Depo Provera).  The most significant obstacle to 
addressing RTIs is the implied social critique that accompanies the issue of RTIs and the gender 
power questions this problem raises.  Such questions, some of which are noted below, may 
threaten traditional political and social structures. 
 
 · Should men shoulder the blame for women's health? 
 
 · Is it fair—or is now the time—to examine traditional male behavior and make 
normative judgements or propose change? 
 
 · Is there a need to make men do things they might not otherwise choose to do, 
including using condoms? 
 
 The issue of RTIs raises questions regarding widely-held assumptions about sexuality.  
Not surprisingly, talking about sexual encounters makes people uncomfortable.  The data 
available indicate, however, that often, sexual encounters are not voluntary, pleasurable, or safe 
for women, who may lack control over the number of partners they have, the timing of sexual ac-
tivity, men's behavior, and contraceptive use.  Confronting the problem of RTIs requires facing 
these troubling issues. 
 Despite the difficulties outlined above, we have begun to study RTIs in both quantitative 
and qualitative ways, as the agenda of this meeting indicates.  We have tried to determine if it is 
important to quantify the extent of the problem, and, if so, among which groups?  The general 
population?  Particular regions?  We have also examined the utility of community and individual 
perceptions gathered through qualitative research.  Whose perceptions are we interested in?  
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Women's?  Men's?  Special groups'?  Special regions'?  How can we best use the information 
gathered through both qualitative and quantitative research?  For program planning?  For political 
ends?  For advocacy?  To improve research? 
 We are also looking very carefully at various prevention strategies.  While we have some 
guideposts, we do not yet have a clear road map on this issue.  There are numerous areas that 
demand further exploration, including:  the role of information, education, and counseling; quality 
of care and provider practices; the extent to which condom promotion is a realistic prevention 
strategy; and the extent to which women's empowerment—including access to resources, legal 
rights, and their ability to make choices and participate equally in the nature of and 
decisionmaking regarding their relationships with men—can be seen as a prevention strategy.  
We also need to examine treatment as a prevention strategy, in that it protects the individual and 
the community and may prevent other diseases, such as AIDS.  We face a major dilemma in this 
area, and must determine who should be treated, and when they should receive treatment.  We 
must also examine community and individual definitions of illness, and the role of these definitions 
in the development of prevention and treatment strategies. 
 There are a few things that we can say with confidence.  We know that there exists 
widespread incidence of RTIs and that the specific patterns of these infections vary:  some are 
STDs, some are not; and some are more serious than others.  We know that we disagree on the 
infections that merit the most focus, and why.  There is also a lack of understanding among 
women about the etiology, seriousness, and range of infections.  In addition, clinicians lack an 
understanding of the problem and do not have the ability to provide appropriate information or 
detect cases.  Finally, we know that we have little or no information on program approaches and 
that we are unable to give clear advice to policymakers and program managers. 
 As we convene this gathering to discuss this complicated issue, we hope to: 
 
 · examine how to use the tools and information available from quantitative and 
qualitative research in both advocacy and program planning; 
 
 · learn about the approaches to service delivery that may be most fruitful; and 
 
 · examine whether we should change our direction and/or the type of the research 
we are conducting on this topic.  
 
 In some ways, this meeting is part of an ongoing internal discussion.  The agenda 
focuses on a number of collaborative projects in which the Council has participated, although 
others will also be discussed.  We hope that by sharing our results and thinking to date we will 
help others who also struggle with these issues, and we are sure that your contributions will help 
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us immeasurably as we move forward with our own work on RTIs.   
 
Christopher Elias  
The Population Council  
Bangkok, Thailand 
 
 
 While there are many unanswered questions regarding reproductive tract infections 
(RTIs), interest in the issue has increased and our thinking has evolved considerably over the last 
several years.  A broad outline of issues related to RTIs, which I hope will help start our 
discussions, is outlined below.  The remainder of the meeting will shed further light on these 
issues and give us an opportunity to discuss their implications for programs.     
 
Definitions 
 There are three types of RTIs: 
 1. Sexually transmitted diseases (STDs). 
 
 2. Endogenous infections:  infections, such as bacterial vaginosis and candidiasis, 
caused by overgrowth of microorganisms normally present in the vagina. 
 
 3.  Iatrogenic infections:  infections associated with medical procedures, such as 
unsafe abortion, IUD insertion, and labor and delivery practices. 
 
 As this list indicates, RTIs have different determinants.  They also have different conse-
quences.  As a result, they require different intervention strategies. 
 
Prevalence studies 
 Prevalence studies have found that RTIs are extremely common and that prevalence 
rates are extremely variable. There is no readily discernible pattern of prevalence to help us 
determine which women are most in need of services.  These studies have highlighted a number 
of problems, including the fact that many infections are asymptomatic.  In addition, perceptions of 
symptoms do not correspond well with recognizable clinical syndromes as defined by biomedical 
paradigms.  That is, a woman in a village may have a name or a way of describing her illness that 
may or may not have very much to do with its clinical name, for example gonorrhea, chlamydia, or 
syphilis.  We have also learned that clinical and lab results vary tremendously in terms of their 
diagnostic utility, revealing differences in diagnostic criteria as well as clinical acumen.   
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Consequences of RTIs 
 RTIs have a broad range of consequences for both women and children.  Women face 
possible infertility, ectopic pregnancy, chronic pelvic pain, and a higher risk of HIV infection;  and 
infants exposed to congenital infections (gonorrhea, chlamydia, syphilis, herpes simplex) may 
develop serious problems. 
 RTIs also have an impact on family planning programs.  By compromising fertility, 
pregnancy outcome, and child survival, they may decrease the demand for contraception.  If RTIs 
are seen as possible side effects of contraceptives, women may not use them.  In addition, there 
are real and perceived associations between RTIs and particular contraceptive methods that may 
result in client or provider bias against these methods.  Finally, while many infections are 
asymptomatic, women often come to family planning clinics with complaints related to RTIs when 
they are symptomatic.  If providers are unprepared to deal with the complaint that prompted the 
visit, because they are not trained to do so or do not have the necessary equipment or supplies, it 
diminishes their credibility with the women they serve, in addition to jeopardizing the health of 
women who do, in fact, have infections.  
 
Determinants of RTIs 
 The following framework, which was developed by Judith Wasserheit and Ward Cates, 
helps us to understand the range of factors that affect RTI patterns. 
 Microbiological determinants influence an individual's likelihood of having an RTI.  
Changes in vaginal flora, and the existence of other RTIs, may be important.  Hormonal factors 
(including cervical ectopy and mucous), seminal fluid, and changes in the immune system (related 
to pregnancy or HIV, for example) also influence an individual's susceptibility to infections. 
 Personal environments also affect the likelihood of infections with certain organisms.  A 
woman's sexual behavior—including her number of sexual partners, age of coital debut, 
participation in commercial sex, and whether her partner has intercourse with commercial sex 
workers—can make her more susceptible.  Her health behavior—including use of condom/ barrier 
methods, oral contraceptives, IUDs, intravaginal preparations, and vaginal douches—also 
influences her susceptibility.  Circumcision also affects individuals' risk of infection.  While the 
effect of male circumcision is protective, particularly for viral infections such as HIV and chancroid, 
some researchers have raised the concern that female circumcision may increase the risk of 
some infections.  Finally, whether and how infected individuals seek help when they feel that they 
have an infection is also an influential factor.  
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 Macro-environmental factors—including socio-economic, political, demographic, 
geographic, and technological factors—also influence the transmission, identification, and 
treatment of infections. 
 
Framework for intervention strategies 
 Designing and implementing appropriate services will require the coordination of diverse 
inputs, including personnel, financial resources, and service structures, the availability and pattern 
of which are highly variable.  There are, however, common elements for an intervention 
framework, as outlined below.  
 Primary prevention of infections  Strategies to prevent STDs include delaying coital debut, 
reducing the number of sexual partners, and promoting condoms; preventing endogenous 
infections by improving knowledge of physiology and hygiene, and encouraging appropriate use of 
antibiotics; and preventing iatrogenic infections by improving the quality of abortions, IUD 
insertion, and childbirth practices.   
     Identification and/or treatment of established infections  While many women are 
asymptomatic, many of those with symptoms do seek help from service providers.  Standardizing 
case management is very important, but in doing so, we should think critically about the risk-
assessment component of some of the algorithms being recommended.  We also need to screen 
for asymptomatic infections.  Diagnostic tests for RTIs tend to be expensive and would have to be 
rationed, but we could use selective case finding for high-risk populations.  We need to move 
beyond the question of "Do we notify partners?" to determining how to do so in a culturally sensi-
tive way.  Mass or epidemiological treatment has also been suggested as an intervention strategy, 
but it requires evaluation, the latter of which must include an evaluation of the costs of emerging 
antibiotic resistance in a community.   
 Minimizing the complications of infection  This approach is costly, but also has a poten-
tially high yield.  Its stakes are also higher, insofar as it implies dealing with infections that exist 
and are progressing or have progressed to a later, more critical phase.  Specifically, we can work 
to improve: 
 
 · the management of septic abortions;  
   
 · early identification and treatment of pregnant women with syphilis; 
 
 · alarm and transport mechanisms for the management of ectopic pregnancy; 
 
 · infertility management; and 
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 · cervical cancer screening and management. 
 
 
The above provides a broad overview of the issues surrounding RTIs, which we will discuss in 
more detail as the meeting progresses.   
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 UPDATE ON STD DIAGNOSIS 
William M. McCormack 
State University of New York  
Health Science Center 
Brooklyn, New York 
 
 
 There are five basic approaches to diagnosing infection: 
  1.  visualizing the organism directly; 
  2.  using antibody tests that measure the body's response to the organism; 
  3.  growing the organism using a culture preparation;  
  4.  searching for antigens using non-amplified techniques; and 
  5.  searching for antigens using amplification. 
 Specific organisms can be diagnosed by using more than one of the approaches listed 
above.  Chlamydia and Human papilloma virus (HPV) are the most complex infections to 
diagnose.  A summary of the ways to diagnose various reproductive tract infections (RTIs) is 
provided below. 
 
Chlamydia 
 Chlamydia can be visualized, but no one uses this method of diagnosis.  Similarly, there is 
no value to using an antibody test.  Currently, the "gold standard" for diagnosing chlamydia is to 
use a culture preparation.  This, however, is expensive and complicated.  DNA probes have been 
available for about a decade and while they are probably about 80 percent as sensitive as culture 
preparations, they are about 99 percent specific1.  Amplified antigen detection tests are about 15–
20 percent more sensitive and specific than culture techniques.  These new amplified antigen 
detection tests, such as polymerase chain reaction (PCR) and ligase chain reaction (LCR), can 
pick up antigens in urine, which is important from a public health perspective in that it implies that 
screening can be conducted in a wide variety of locations.  While these tests currently cost about 
US$20 each, they will be cheaper in volume. 
 
Gonorrhea 
 A gram stain is a very good diagnostic test for gonorrhea in men.  For both men and 
women, with or without symptoms, culture is an excellent diagnostic test if an incubator, 
                                                     
    1 Ninety-nine percent specificity is an important clinical concept.  It means that if you test 100 women who are 
negative, 99 of them will have negative test results, or, if you test 100 women who are negative, 1 will test positive. 
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technician, and other necessary supplies are available.  While there is not, given the above, a 
compelling reason for developing non-culture tests, industry has developed them, and they are 
marketed in tandem with chlamydia tests. 
 
Genital ulcers 
 In most parts of the world, genital ulcers are the result of syphilis, herpes, and/or chan-
croid.  Tests to diagnose these illnesses in the ulcer phase are only available on a limited basis 
and are imperfect, at best. 
 
Syphilis 
 There is a dark-field test for primary syphilis, but it requires a dark-field microscope and 
technician, both of which are very expensive.  Direct fluorescent antibody staining is possible, but 
also requires a microscope and technician.  No antigen detection tests are on the market.  In all 
stages, syphilis is usually diagnosed by serologic tests.   
 
Herpes 
 The herpes virus can be visualized using a "Tzanck prep," which involves staining for the 
strange-looking cells that it induces.  This is an insensitive test, however, and not widely used.  
Culture is the "gold standard" for diagnosis of herpes lesions, but is expensive and requires a lab. 
 Antigen detection tests are available, but are less sensitive than culture.   
 
Chancroid 
 It is possible to look for chancroid organisms using a gram stain, but this is insensitive 
and not widely used.  No useful blood test exists. Chancroid can be grown, but this requires 
special media and labs.  Antigen detection techniques are not yet available.   
 
Human papilloma virus (HPV) 
 We are currently in the initial stages of understanding the HPV organism.  It cannot be 
visualized directly.  You can look for changes in cells, but there is no blood test available and the 
organism cannot be grown in culture.  It can be categorized on the basis of DNA probes.  Other 
diagnostic tests are under development that will improve on the DNA probes.     
 We should not be making HPV treatment decisions based on the results of inadequate or 
inaccurate diagnostic tests.  The treatment options available are not only ineffective, but also 
potentially harmful.  Currently, HPV management relies on Pap smears.  Diagnosing HPV 
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requires looking for changes brought on by the organism instead of the organism itself.  Patients 
who have abnormal Pap smears, most of which are due to HPV infection, should be referred to a 
gynecologist. 
 
Trichomoniasis 
 Trichomonas vaginalis can be visualized in direct wet preparations.  No useful blood test 
exists.  The organism can be cultured and cultures add 10–15 percent to the yield over wet 
preparations, particularly in asymptomatic individuals.  There are no marketed antigen detection 
tests for trichomoniasis, but they are under development. 
 
Candidiasis 
 Candida organisms can be seen in wet preparations or in gram stains of vaginal material. 
 Sensitivity, however, is only 60 percent when this approach is used.  No useful blood test exists.  
Candida organisms can be grown in culture, which is the "gold standard" for their diagnosis.  Anti-
gen detection tests have been developed for candida, but none of those that are presently on the 
market are useful for the diagnosis of vulvo-vaginal candidiasis. 
 
Bacterial vaginosis 
 Bacterial vaginosis is the absence of normal vaginal flora or the replacement of normal 
vaginal flora with abnormal vaginal flora.  Clinical diagnosis involves measuring vaginal pH, de-
tecting abnormal odor after alkalinizing the secretions, and noting whether the secretions are 
abnormal in appearance.  This approach requires a microscope, but could be used in any area of 
the world.  There has been interest in developing antigen detection tests. 
 
 
 COMMENTARY 
Vilma Barahona 
Hospital General Aurelio Valdivieso 
Department of Clinical Pathology 
Oaxaca, Mexico 
 
 Reproductive tract infections (RTIs) are extremely common and can have serious conse-
quences for the health and social well-being of women in developing countries.  They are, howev-
er, preventable, and can be treated.  Because Pap smears are relatively cheap in the developing 
world, they are a useful means of screening for reproductive morbidity.  Risk for or presence of 
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RTIs should be taken into account in the development and delivery of all services related to family 
planning, safe motherhood, and AIDS prevention. 
 In addition, research on RTIs must take into account the conditions in which women live 
and the economic, political, cultural, and social context that defines the relationships between 
women and men.  In Mexico, for instance, as poverty becomes more widespread, an increasing 
number of men from rural areas migrate to the north and to the U.S. in search of work, and more 
women are forced to trade sex for money in order to survive.  These problems increase the 
prevalence of RTIs, as well as AIDS.  
 Like most of my colleagues, I read journals and attend international conferences.  Upon 
returning home, however, I am faced with the reality of old and obsolete machines, a lack of office 
and laboratory equipment, a scarcity of well-trained technicians, and many other constraints.  I am 
forced to identify other means to carry out my work within these constraints, which is a difficult and 
tiring task.   
 In summary, when considering advances in technology and research, we also need to 
consider ways to facilitate technology transfer at a reasonable cost.  We must keep in mind that 
the transfer of new information and technology is not automatic, and is often hampered by socio-
economic conditions. 
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 DEFINING THE SCOPE OF RTIS:  QUANTITATIVE RESEARCH 
 
Kathryn Tolbert 
The Population Council 
Mexico City, Mexico 
 
Introduction 
     The work I will report on represents an ambitious first project for the Health Research Center 
of Comitán.  For the Population Council, it has served as a pilot study for a larger, comparative 
study of reproductive tract infections (RTIs) in two other states in Mexico.  Ultimately, we will have 
data from three states on the prevalence of RTIs, and on aspects of sexual behavior which may 
relate to the presence of infections. 
 
Quantitative study 
 The clinical research was conducted at the Comitán general hospital and laboratory.  Both 
the general medicine outpatient clinic (GMC) and the gynecology clinic (GC) contributed patients 
for screening.  A total of 416 women seeking a range of services from the two clinics were 
studied.  Enrollment was undertaken through clinical census.  To be enrolled, women needed to 
be over 15 years of age and attending one of the clinics.  Pregnant women were not excluded, but 
the data collected on these women were analyzed separately.  An additional 93 women who had 
participated in community development projects in four periurban communities around Comitán 
were also studied, as were 108 women from a nearby collective farming community (ejido).  
These women represented a convenience sample, and were enrolled by invitation.  The study was 
explained to the women and they were told they would be given a physical exam and Pap smear, 
informed of the results, and, if an infection was detected, be treated.  Their consent was obtained 
and noted.  
 
Methodology   
 A short questionnaire was administered to gather demographic, health, and risk 
information.  The women were also given a pelvic exam and Pap smear.  Samples were taken 
and the results of the physical exam were noted on each patient's record.  Diagnostic tests were 
performed for the following: 
 
 · Syphilis, by VDRL test 
 · Gonorrhea, by immediate microscopic exam and culture 
 · Trichomoniasis, by immediate microscopic exam 
 · Chlamydia trachomatis, by ELISA test on endocervical brushings and cell culture 
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 · Moniliasis, by immediate microscopic exam 
 · Bacterial vaginosis (a syndrome of profuse vaginal discharge with a characteristic 
odor, a pH of less than 5, and large numbers of white cells and "clue cells"), by 
microscopic examination 
 
 Because of budget limitations, only a subsample of each group was tested for chlamydia. 
  
 
Results 
 There were no significant differences among the women from the two clinics in terms of 
age, schooling, civil status, age of menarche, age at first pregnancy, or number of living children.  
There were, however, differences in pregnancy status:  51 percent of the women attending the 
GMC were pregnant, compared to 15 percent of those attending the GC (see Table 1). 
Table 1 
 
Comitán General Hospital Population 
Clinic Mean 
age 
School 
(none or 
incomplete) 
Civil 
status 
Average 
age at 
 first 
pregnancy 
Average 
number of 
live 
children 
Pregnant 
   Married In union    
GMC 
(n=250) 
 
30 
 
73% 
 
66% 
 
29% 
 
18.6 
 
3.1 
 
51% 
GC 
(n=166) 
 
33 
 
75%  
 
63% 
 
28% 
 
18.8 
 
3.5 
 
15% 
 
 
 The women who attended the clinics came almost exclusively for reproductive health 
problems.  They complained of pain, menstrual difficulties, postpartum difficulties, pregnancy-
related concerns, and symptoms that might indicate the presence of RTIs, such as burning, 
itching, ulcers, "bumps," and lesions in their lower reproductive tract.  
 The levels of RTIs found in the sample of 416 women who attended the Comitán General 
Hospital clinics were higher than expected, with more than 50 percent of women testing positive 
for one or more pathogens.  Of particular interest was the fact that 12.4 percent of the subsample 
of 145 women tested for chlamydia were found to have the infection.  This is the same level of 
prevalence as that found in a sample of commercial sex workers in Chiapas (Tapachula) by a 
Health Secretariat study.  Both gonorrhea and syphilis rates are low (there were no cases of 
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syphilis), perhaps representing the ready availability of antibiotics (over-the-counter without 
prescription) and their frequent use for respiratory and intestinal infections.   
 Specific infection rates are reported separately for pregnant and non-pregnant women. 
The pregnant women were slightly more educated than the non-pregnant women, with 63 percent 
reporting no schooling or incomplete primary education.  This is probably due to the fact that the 
non-pregnant group includes the older women in the study, who probably have less education 
than the younger women due to advances in extending education to women in the last two 
decades.  No other socio-demographic variable was significantly different for pregnant women. 
 Infection rates, and particularly sexually transmitted infection rates, do not vary 
significantly between the clinics (Table 2).  Pregnant women, however, differ significantly from 
their non-pregnant counterparts in this regard, with a higher rate of Candida infections and a 
surprisingly low rate of chlamydia infection.   
Table 2 
 
Percentage of Women with Infection (by pathogen): 
Comitán General Hospital Outpatient Sample 
 
Pathogen 
GMC Non-pregnant 
(n=123) 
GC Non-pregnant 
(n=140) 
Pregnant (both sites) 
(n=153) 
Syphilis 0 0 0 
Gonorrhea 2.5 (n=120)  2.1 0 
Trichomonas 5.7 2.1 3.8 
Candida 15.4 21.4 33.1 
Bacterial vaginosis 28.5 27.1 25.5 
Chlamydia 15.6 (n=45)  16.7 (n=60)  2.5 (n=40)  
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 In the periurban/ejido group (n=201), only 
three women were pregnant, so analysis was not 
conducted separately by place of residence.  One of 
the three pregnant women tested positive for 
chlamydia.  The infection rates for this group are 
presented in Table 3. 
 Additional findings from the physical exam 
are also troubling.  In the hospital sample, four 
cases of previously detected invasive cancer, and 
six cases of carcinoma in situ, were noted.  In the 
community sample, two cases of carcinoma in situ 
were detected. 
 
 
 
 
 In summary, the data collected indicate the following: 
 
 · Infection rates are high among these women (particularly for candida, bacterial 
vaginosis, and chlamydia) 
 · Cervical ulceration is common, and vaginal condyloma rates are high among the 
women in the community sample  
 · There is substantial unanimity of results between the two recruitment sites (hospital 
and community samples) 
 · Where it could be measured with sufficiently large numbers, pregnant women seem to 
have more candida infection and less chlamydia infection  
 · Chlamydia infection rates are much higher than predicted based on other developing 
country prevalence data and on the results of a study of a high-risk sample 
(commercial sex workers) in Mexico 
 · In general, women in the community sample had greater infection levels for each 
pathogen, despite the fact that they had similar socio-demographic characteristics 
 
 
 
 
 
 
 
 
 
 
Table 3 
 
Infection Rates Among Periurban 
and Ejido Women 
Pathogen Infection Rates 
Syphilis  0 
Gonorrhea  0 
Trichomonas  18/201 = 9% 
Candida  12/201 = 5.8% 
Bacterial Vaginosis  76/201 = 37.8% 
Chlamydia  27/141 = 19.1% 
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Eugenio Pacelli de Barreto Teles 
Federal University of Ceara 
Department of Community Health 
Fortaleza, Brazil 
 
 In our study, we examined 407 sexually active women who were attending the family 
planning clinic at the State University of Campinas to initiate use of a contraceptive method.  The 
clinic is well known to be the only public facility in the city that provides intrauterine devices (IUDs), 
and is therefore heavily oriented toward IUD service delivery.  To some extent, women probably 
self-select before attending this clinic, because they know that the clinic will not provide IUDs to 
women who are not in monogamous relationships.   
 All patients enrolled in the study were screened by clinical exam, history, and laboratory 
findings.  Researchers used saline wet mount to diagnose bacterial vaginosis (BV), candida, and 
trichomoniasis; gram stain to diagnose gonorrhea, BV, candida, and trichomoniasis; Pap smear 
for human papilloma virus (HPV); culture for gonorrhea; and fluorescent test for chlamydia.  
Prevalence rates are indicated in Table 1.  The clinical and medical history was used to exclude 
women who were felt to be inappropriate candidates for IUD use based on the likelihood of 
sexually transmitted genital infection.  If cultures later revealed that an IUD had been inserted 
inadvertently into a woman with a pre-existing infection, the woman was called as soon as the 
results were known, and treated.  Some women returned to the clinic with symptoms of infection 
prior to hearing of the laboratory findings. 
Table 1 
 
Reproductive Tract Infection Prevalence 
 % Prevalence 
of infection  
(all women) 
(n=407) 
% Prevalence of 
infection among IUD 
acceptors  
(n=327) 
% Prevalence of infection 
among all non-IUD family 
planning acceptors (n=80) 
B. vaginosis 25.8 25.1 28.8 
Chlamydia 6.7 5.9 10.0 
Candida 2.2 2.4 1.3 
Trichomoniasis 1.7 2.1 0.0 
HPV 1.0 1.2 0.0 
Gonorrhea 0.0 0.0 0.0 
No infection 64.1 66.0 62.0 
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 When clinical and medical histories were compared to the laboratory results, the clinical 
predictors were found to be surprisingly inadequate.  Of all the reproductive tract infections (RTIs) 
examined, clinical diagnosis of BV resulted in the fewest false positives by a large margin.  
Overall, however, the efficacy of clinical diagnosis was unsatisfactory; the indicators tended to be 
of low sensitivity and to generate high proportions of false positives (see Table 2). 
Table 2 
 
Accuracy of the Clinical Diagnosis of Genital Infections 
Infections Sensitivity Specificity False + False - 
Chlamydia  7.4  92.8  93.1  6.7 
Trichomoniasis  42.9  96.5  82.4  1.0 
Candida  33.3  97.0  80.0  1.5 
B. vaginosis  41.0  90.7  39.4  18.5 
 
 
 The prevalence of genital infections among IUD acceptors was lower than among the 
acceptors of other methods, although this was not statistically significant.  Out of the 327 IUD 
acceptors, 19 tested positive for chlamydia, two of whom developed clinical signs of pelvic 
inflammatory disease (PID).  One of these women was treated with drugs, but retained her IUD; 
the other was treated with drugs and had the IUD removed.   
 We found that, despite relatively little "high risk" sexual behavior, new acceptors of 
contraception had a significant prevalence of chlamydial cervicitis and were not easy to identify 
through any means other than laboratory examination.  This underscores the need for cheaper 
and simpler diagnostic tests, but also suggests a simultaneous need to explore alternative options 
for improving the safety of contraceptive service provision.   
 
Joan Kaufman 
Abt Associates, Inc. 
Cambridge, Massachusetts 
 
 The study on which I will report was carried out in collaboration with Professor Yan Liqin 
and her colleagues at Kunming Medical College in Kunming, the capital of Yunnan province, 
China.  We decided to conduct the study because previous research had found high rates of 
vaginitis and cervicitis in Yunnan, suggesting underdiagnosis of reproductive tract infections 
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(RTIs).  Yunnan, which is located in southwest China, borders Burma, Laos, and Vietnam.   
 Other studies and factors point to high RTI prevalence in China.  I will discuss some of 
these briefly before moving on to our results of the study in Yunnan.  In 1992, the Ford Foundation 
carried out a reproductive health survey of 8,500 women in China, which revealed high rates of 
self-reported vaginitis and vulval itching.  National statistics indicate that more than 40 percent of 
women who use contraceptives, or 60–70 million women, use IUDs and abortion rates are high as 
well, providing an opportunity for iatrogenic infection at lower level clinical facilities, where many of 
these procedures are performed.  Sexually transmitted disease (STD) rates are rising nationwide, 
and especially in urban areas.  Within the last few years, sexual transmission of human 
immunodeficiency virus (HIV) has increased.  China's tremendous population movements from 
the rural areas to the cities and migrant workers moving from city to city also influence HIV 
prevalence patterns.  Yunnan, however, accounts for 80–90 percent of China's HIV, mainly 
concentrated among injected heroin users near the Burmese border. 
 The Yunnan study mandate was two-fold.  We began by compiling and reviewing existing 
information on RTIs in China from a variety of sources.  Although Ministry of Health officials often 
say there are no cases of pelvic inflammatory disease (PID) or STDs in the country, the incidence 
of STDs has been rising, as noted above and as many small, but unconnected, studies reveal.  
Our literature review compiled existing information on RTIs and STDs in China, and we tried to 
answer several questions, including:  What has been done in China regarding RTIs and STDs?  
What services are available?  Are RTI treatments standardized?  How much do they cost? 
 We found that, as 
suspected, rates of 
cervicitis in China are high.  
In a variety of studies 
conducted in different areas 
of the country, rates of 
visually observed cervicitis 
were found to be 60–70 
percent.  We also learned 
that there is little capacity to 
diagnose RTIs below the 
county level of service, 
while most people seek health services at the township level (Table 1).  In addition, the treatment 
of symptoms varies widely.  Some women are treated with traditional medicine, while others 
Table 1 
 
STDs For Which Different Hospitals/Health 
Centers Have Testing Capacity 
 
Items 
 
Province 
City/ 
County 
 
Township 
 
Village 
Trichomonas 100% 76.1 -- -- 
Candida 100% 76.1 -- -- 
Gonorrhea 100% 61.8 -- -- 
Syphilis 100% 47.1 -- -- 
Chlamydia 100% -- -- -- 
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receive antibiotics.  Laser therapy is used for more serious cervicitis, which is worrisome given the 
possible ill effects of this procedure.  Our primary conclusion was that there is an urgent need to 
improve the clinical diagnosis of cervicitis and to determine its underlying etiology (for example, 
whether it is related to STDs or other RTIs). 
 Following the literature review, we carried out a field survey in two Yunnan counties, 
Chengjiang and Luliang, which are about 100 kilometers from Kunming.  Our aims were to estab-
lish the prevalence of RTIs and examine health, socio-economic, and behavioral risk factors.  
Data were collected using a questionnaire on social and behavioral risk factors; conducting clinical 
exams for symptoms; and conducting lab tests for candida, trichomoniasis, bacterial vaginosis, 
gonorrhea, and chlamydia.  Local field testing was followed by a "gold standard" test in Kunming, 
to confirm the presence of infection and assess lab capacity at the local and central levels. 
 Rates of cervicitis were 
found to be alarmingly high, 
although rates of specific RTIs were 
lower (Table 2).  In examining 
possible determinants, preliminary 
analysis of the data showed the 
following:  most women have ac-
cess to tap or well water (water puri-
ty is good in China); the frequency 
of bathing varies greatly (32 percent 
of women bathe once a week and 
68 percent bathe less than once a 
week); the rate of IUD use (45 
percent of current contraceptive 
users) is similar to the national level; 
21 percent of the women had had 
one abortion, while 8 percent had had more than one.  Self-reported symptoms revealed 
disturbingly high levels of morbidity (37 percent reported itching, 35 percent reported abnormal 
discharge, and 53 percent reported malodorous discharge).  Analysis of risk factors is continuing 
and the results should be available in mid-1996.   
 Our qualitative work was not as successful, due primarily to the difficulties of carrying out 
anthropological research in a country where social science research has been taboo for more 
than 30 years.  We did succeed in eliciting some interesting information, however.  The women 
Table 2 
 
Preliminary Results: Findings from RTI Baseline Survey 
in Chengjiang and Luliang (N=2020) 
Diseases Cases Rate (%) 
Normal women 379 18.8 
Cervicitis 1176 58.2 
Candida vaginitis 786 38.9 
Trichomonas vaginitis 327 16.2 
Bacterial vaginosis* 175 14.7 
Gonorrhea 7 0.3 
Chlamydia** 90 5.5 
* 1189 women were tested for bacterial vaginosis. 
** 1643 women were tested for chlamydia. 
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surveyed call all RTIs "syphilis," and also have other terms for specific RTIs.   Candida, for 
example, is referred to as "syphilis" or "lower body itching."  If women use the latter term, they 
receive traditional herbal medication, which only works for a short time.  They use graphic names 
for their infections, which are descriptive of the symptoms, including "nasal mucous" for discharge 
and "stool smell" for odor.  Most women do not believe that RTIs are related to sex.  Many believe 
that they are the result of poor hygiene and that they can be caused by an imbalance of hot and 
cold in the body.   
 
Conclusions 
 We are working to convince the local health authorities to pay greater attention to RTIs.  
We hope that our study will help the Ministry of Health refine its definition of cervicitis and 
determine its causes, which is urgent given the high levels of cervicitis and the risk of HIV in 
Yunnan.  We also hope to develop a risk assessment tool for specific RTIs, which could be used 
in Yunnan to help identify women at high risk in order to refer them for further screening before 
IUD insertion or abortion.  Finally, we are also providing training to local health personnel on RTI 
diagnosis and treatment. 
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INDIVIDUAL PERCEPTIONS: QUALITATIVE RTI RESEARCH 
 
Huda Zurayk 
The Population Council 
Cairo, Egypt 
 
 The interdisciplinary research on which I will report focused on gynecological and related 
reproductive morbidity among women in Giza, a rural area outside of Cairo, Egypt.  The study 
group was a community sample of 509 women; eligible participants were ever-married, non-
pregnant women, aged 14–60.  They were primarily non-literate and most were currently married; 
most had been younger than 16 years old when they first married, and had had more than three 
children. 
 Household interviews were 
conducted to collect background information 
on the women and their reported symptoms 
of morbidity.  The women were invited to a 
health center for a clinical exam and labo-
ratory tests.  It was determined that 51 
percent of the women had RTIs, 22 percent 
had cervical ectopy, 11 percent had suspi-
cious cervical cell changes, and 56 percent 
had genital prolapse (see Table 1).  Based 
on these findings, it is clear that women's 
health problems extend beyond those 
related to pregnancy. 
 Our objective was not only to collect 
medical data on the prevalence of 
reproductive tract infections (RTIs) and 
related gynecological morbidity, but to 
compare those findings with women's 
perceptions and investigate health-seeking behaviors related to gynecological symptoms.  We 
found that the majority of women do not use health services when they experience such 
symptoms, because they do not consider them to be abnormal or problematic.  The only type of 
problem a substantial proportion of women perceive as problematic, and as cause for consulting a 
physician, is a delay in conception.  On the other hand, medical consultation was least likely for 
Table 1 
 
Percent Prevalence of Gynecological Morbidities 
Condition % 
Reproductive tract infections (RTIs)* 
 · Vaginitis 
   · Bacterial vaginosis = 22 
   · Trichomonas = 18 
   · Candida = 11 
 · Cervicitis (Chlamydia = 9) 
 · Pelvic Inflammatory Disease 
51 
44 
 
 
 
10 
2 
Cervical ectopy 22 
Suspicious cervical cell changes 11 
Genital prolapse: 
  Posterior or anterior vaginal 
  Posterior and anterior vaginal 
  Vaginal and uterine 
56 
27 
21 
8 
Number of women 502 
*  Some women have more than one RTI 
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problems with intercourse. 
 The women lack awareness of the potentially serious nature of certain RTIs.  Socio-
economic and cultural constraints compound the problem of addressing RTIs:  for example, when 
the study field workers tried to take the women found to suffer from a disease for health care, the 
women did not always have time to go; often field workers had to negotiate for permission from 
the husband or mother-in-law to do so.  Related issues documented by the study include women's 
low position of power within the community, poor economic conditions, heavy workload, and low 
educational status.  Case studies of the women referred for health care were prepared and 
published jointly by UNICEF and the Population Council in a book entitled The Silent Endurance.  
These qualitative texts complement the quantitative data on prevalence, and forcefully show the 
social conditions that constrain the health situation and health-seeking behavior of women.  More 
research is needed on women's perceptions of their health within the context of their socio-
economic and cultural circumstances. 
 As a result of these findings, we decided to begin developing a health education packet 
that will raise the awareness of women about the symptoms of reproductive morbidity and of the 
need for care.   
 
Adepeju Olukoya 
Women's Health Association 
Lagos, Nigeria  
 
 Based on hospital data and the high level of infertility—as much as 50 percent in some 
communities—we know that reproductive tract infections (RTIs) are prevalent in Nigeria.  
Intrauterine devices (IUDs) are one of the most popular means of contraception, a troubling fact in 
the context of Nigeria's resource constraints, serious electricity and water supply problems, and 
probable high infection rates. 
 The objectives of the RTI study we conducted were to: 
 · define men and women's perceptions of reproductive morbidity and, specifically, their 
perceptions of vaginal secretions, sensations, and sores, using a life-cycle approach; 
 
 · describe help-seeking behavior for perceived abnormalities; and 
 
 · define male and female perspectives with regard to the provision of RTI care and fam-
ily planning services. 
 
 The study had two phases, the second of which was truncated due to political problems.  
The methodology used in Phase I consisted of in-depth interviews related to women's experience 
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through the life cycle, including puberty, the reproductive years, and menopause. During this 
phase, we spoke with traditional healers, pregnant women, postpartum women, family planning 
users and non-users, herb sellers, and menopausal women.   
 In studying male and female perceptions of reproductive morbidity, we found that the 
range of normal to abnormal was very wide:  vaginal itching, "hotness," and "tightness" for 
example, are considered normal phenomena at certain times during the female life cycle.  
Similarly, menopause is not seen to have a beginning or an end; if a post-menopausal woman has 
vaginal bleeding, for example, she would simply think she had not yet completed menopause, 
when in fact the bleeding could be a sign of a serious problem.  We found that it is socially 
acceptable for men to network sexually when their wives are pregnant or postpartum, while 
retaining the privilege of returning to their wives for sexual relations.  Interestingly, we found that 
men refer to RTIs and sexually transmitted diseases (STDs) as infections "caught from women."  
We also learned that family planning methods are perceived to be causally associated with 
abnormalities in the genital tract.   
 Most women said that they would talk to traditional healers as the first line of help if they 
felt they had a problem.  Most of the methods that traditional healers use—herbal preparations 
(including their use as pessaries), drinks, and so forth—are either harmful or, at best, do nothing 
to heal the women of their illness.  We were surprised to learn that the traditional healers 
considered foul-smelling or bloody discharge to be abnormal.  Most of the women in the study 
thought of such discharge as normal at some phase of life.    
 Our conclusions were as follows: 
 
 · Given that it is acceptable for a man to "network" sexually and continue to have sexual 
relations with his wife, she and her unborn child are placed at increased risk of RTIs.  As 
such, there are culturally sanctioned increased risks of infection to mothers and children. 
 
 · Widespread misinformation and inappropriate help-seeking behavior affects women 
from puberty through menopause.  These misperceptions are not limited to women of 
poor economic and educational status; educated and economically-privileged women also 
believe that certain types of abnormal discharge and other RTI symptoms are normal. 
 
 · Most women with RTIs are asymptomatic. 
  
 · Current help-seeking behavior may actually increase the incidence of illness. 
 
Nandini Oomman 
Johns Hopkins University 
School of Hygiene and Public Health 
Baltimore, Maryland 
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 The qualitative and quantitative study on which I will report was entitled "Ethnomedical 
models of dhola pani in rural Rajasthani women."  Dhola pani, the local term for white discharge, 
was chosen as the focus of the study because it was a complaint that women frequently made to 
health care providers in this community.  An ethnomedical model is a model of the way in which 
people in a particular community conceptualize an illness with respect to its causes, symptoms, 
pathophysiology, and treatment. 
 The first phase of the study involved ethnographic research.  We began by selecting 
women in the community whom we felt would be good informants about the problem of dhola 
pani.  The objectives of the first phase were to: 
 
 · ask women how they conceptualized the problem; 
 
 · determine if an ethnomedical model existed; 
 
 · determine the appropriate terminology to use to ask women related questions; and  
 
 · generate appropriate instruments for further research. 
 
 The second phase of the study involved a survey to collect information on demographic 
variables as well as on women's menstrual and obstetric histories.  
 The third phase involved clinical examinations.  We used this approach because the facili-
ties to conduct lab tests were not available.  The purpose of the clinical phase was to compare 
reports that women gave regarding dhola pani with clinical findings related to infection. 
 Through our research, we found that women complained of other possible reproductive 
health problems in addition to discharge.  They said that they had equally serious problems with 
continuous bleeding, which they called "feet walking," and various types of prolapse, which they 
referred to as "body coming out."  There were also many different terms used for discharge, 
including "body is melting" and "bones melting" for white discharge, and "brown falls" and "maroon 
falls" for bloody discharge. 
 Using the study findings, we constructed a model based on the way women describe their 
problems.  They believe that economic disadvantage results in worry, anger, lack of food, and too 
much work; these problems lead to physiological weakness, which in turn results in discharge.  
They believe that sterilization, intrauterine device (IUD) insertion, abortion, problems in childbirth, 
eating hot foods, and different sexual intercourse practices are all "opportunistic" factors which 
affect them in their already weakened, vulnerable condition, resulting in discharge.  The women 
also associate several other physical problems with discharge, including backaches, leg aches, 
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sore veins, dizziness and fainting, and panic and anxiety.   
 As noted above, women perceive the root cause of discharge as an economic one.  They 
do not view it as a sign of infection and therefore do not seek care.  They also believe that the 
problem would be solved if they had better nutrition.  A few quotes from the surveys illustrate this 
thinking:  "If there is food in the house, there is no weakness," "Dhola comes from the same place 
as menstrual blood, so when a woman is strong, then blood flows properly.  When she is weak 
and doesn't have her daily food, then dhola falls, her bones melt." It is clear that their 
understanding of the problem is very different from the biomedical model.  
 When women experience discharge, they sometimes seek treatment from traditional 
healers.  Most often, however, they employ such home remedies as use of water chestnut, which 
they feel has high nutritive value.  We also learned that many women speak to no one about the 
problem of discharge, while some speak with their husbands, mothers-in-law, and friends. 
 
Conclusion 
 Women report dhola pani as a symptom of a larger problem, but they think of its etiology 
very differently than it is conceptualized in the biomedical model.  Our clinical work indicates that 
reproductive tract infections (RTIs) are present in this community, but women's perceptions of the 
problem are such that they do not think that curative or preventative means for dhola pani are 
available.  Sex and health education will thus be key in helping them to accept the role of health 
care and to seek it when they face this problem. 
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THE UTILITY OF ALGORITHMS AND RISK SCREENING 
 
Earmporn Thongkrajai 
Community Health Development Project 
Department of Medicine and Surgical Nursing 
Khon Kaen University 
Khon Kaen, Thailand 
 
 
 Conventional sexually transmitted diseases (STDs) are a major public health problem:  
they represent 20 percent of medical consultations in some developing countries and are among 
the top five reasons for which medical advice is sought.2  In sub-Saharan Africa, they are thought 
to be responsible for 17 percent of productive life-years lost to disease.  For women, in particular, 
STDs present a severe threat to health and well being—in addition to pain and discomfort, STDs 
may also cause long-term reproductive health problems, such as infertility and chronic pelvic pain. 
 Sexually acquired infections may also lead to ectopic pregnancy and cervical cancer, which can 
lead to death. 
 The provision of services to asymptomatic women is an essential part of STD programs, 
both to prevent complications and sequelae, and to interrupt the transmission of infection.  
Without such services, STDs cannot, by definition, be controlled.  Even in countries with the best 
developed STD prevention and control programs, services tend to concentrate on the treatment of 
those who seek care because they have symptoms.  Many women, however, will be 
asymptomatic, and thus undiagnosed, prior to the development of complications.  Others are 
either unaware of the significance of symptoms or are reluctant to seek care for fear of 
stigmatization.   
 Maternal and child health and family planning (MCH/FP) programs are in a unique 
position to assist in reducing the spread of STDs and human immunodeficiency virus (HIV) (80 
percent of women with HIV infection are of reproductive age).  Not only do such programs employ 
the largest pool of health personnel, but they also have experience dealing with such interventions 
as counseling and the provision of contraception, which are closely related to the prevention of 
STDs, including HIV.  If these programs played a more active role in primary prevention, by 
encouraging behavior change, and in secondary prevention, through effective case management, 
they would reach many women.  In addition, some women obtain health services, either for their 
children or for themselves, only through MCH/FP programs. 
                                                     
    2 WHO/GPA. Provision of STD Services in Maternal and Child Health and Family Planning Setting, Background 
Paper No. 8, June, 1992. 
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 An essential element in testing the feasibility of integrating STD services into MCH/FP 
programs is the choice of a method for diagnosis and case management for asymptomatic 
women and those who do not report symptoms.  To address this, a study conducted in Thailand 
developed an algorithm for diagnosis and management of STDs among women attending family 
planning and antenatal clinics under the MCH/FP program in the Chumpae district hospital in 
Khon Kaen province.  The specific objectives of the study were to determine the prevalence of 
STDs and associated risk factors among women attending the clinics, and to validate a risk score 
for STD management among women who do not report symptoms. 
 
Study summary 
 Women presenting to family planning and antenatal clinics in the Chumpae district 
hospital during a period of ten weeks were included in the study, along with some additional 
women from the Nampong district, which is similar to Chumpae.  A total of 793 women were 
enrolled.  Identical data collection procedures were followed—a physical examination, specimen 
collection and testing for STDs, and a screening interview.  Data analysis of the pooled cases was 
conducted as a preliminary attempt to develop and validate the algorithm.  
 Focus groups  Four focus groups were held among women aged 18–45 from villages 
served by the Chumpae district hospital.  The objective was to explore and gather information on 
women's perceptions and beliefs regarding possible symptoms related to STDs.  Of particular 
interest were their definitions of and the terms they used for vaginal discharge, itching, malodor, 
lower abdominal pain, difficulty with urination, and discomfort or tenderness around the cervix.  
Information was collected on their knowledge, attitudes, beliefs, sexual behavior, and preventive 
and curative behaviors.  This information was then used to prepare the questionnaire for 
structured interviews, described below. 
 Interviews  Each woman attending the MCH/FP clinic was interviewed by a health worker 
using a structured questionnaire.  Information was collected on the following: 
 
 · personal characteristics: age, education, occupation, marital status, place of residence 
 · number of induced abortions 
 · previous STD(s) 
 · perceived risk of STD 
 · risk factors for STDs: age at first intercourse, number of sexual partners in the last 
year, duration of relationship with current partner, duration of marriage, change of 
partner in last three months  
 ·  husband or partner's age, occupation, education, residence, STD status, length of 
time away in past three months 
 · contraceptive use 
 · current symptoms: dysuria, vulvo-vaginal itching, dyspareunia, lower abdominal pain, 
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vaginal discharge, genital ulcers, skin rashes 
 
 Physical examination  Vaginal, cervical, urine, and venous blood specimens were 
collected.  On-site lab tests were performed for T. vaginalis, C. albicans, bacterial vaginosis, N. 
gonorrhea, C. trachomatis, and syphilis.  A bimanual pelvic examination was also carried out.  All 
women were examined for the following: 
 
 · skin, sole, and palm rashes 
 · vaginal discharge (type, color, odor) 
 · cervical discharge (after cleaning), and whether mucopus  
 · cervical dysplasia/ectropion (whether contact bleeding), cervicitis 
 · genital ulcers 
 · genital warts 
 · condyloma lata 
 · anal alterations (ulcers, rectorrhea warts) 
 
 Health education and treatment   All participants received advice and information on 
HIV/AIDS, and were offered a supply of condoms at the initial visit. Infected patients were treated 
according to the regimen used at government STD clinics. 
 
Results and discussion 
 Study results indicate that the 
prevalence of chlamydia is slightly over 3 
percent—about half the rate expected based 
on earlier data—while the prevalence of 
syphilis and gonorrhea are under 1 percent 
(Table 1).  Women whose husbands often 
worked away from home and who had not 
lived with their husbands during the past 
three months had significantly higher rates 
of chlamydia than women whose husbands 
were away less frequently or who had lived 
with them in the past three months (Table 
2).  Women who reported lower abdominal 
pain had significantly higher rates of 
chlamydia than women who did not report 
this problem.  No relationship was found between chlamydia infection and reports of dysuria, 
vaginal discharge, and vaginal itching.  A positive leukocyte esterase dipstick (LED) test, however, 
 Table 1 
 
Prevalence of STDs Among Women Aged 
15–39 Years in Pooled Sample (N=793) 
 
 STD 
 
Percent 
 
Positive syphilis serology* 
 
0.6 
 
Gonorrhea 
 
0.1 
 
Chlamydia 
 
3.3 
 
 * RPR and TPHA tests both positive 
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was found to be associated with the presence of chlamydia.  More than twice as many women 
tested positive, rather than negative, for the infection. 
 A logit regression analysis was conducted to determine the association of chlamydia with 
each of the four risk factors identified—frequency of the husband working away from home, 
husband and wife living together during the previous three months, lower abdominal pain, and a 
positive LED test.  The only factor that did not remain significantly associated with chlamydia 
prevalence was a positive LED test. 
Table 2 
 
Proportion of Women in Pooled Sample Infected and Uninfected with Chlamydia by 
Selected Characteristics 
 
 
 Characteristic 
 
 Infected 
  % 
 
 Uninfected 
 % 
 Total  
    %  N 
Age (in years) 
  15–19 
  20–24 
  25–29 
  30–34 
  35–39 
 
2.2 
4.9 
3.1 
2.3 
2.0 
 
97.8 
95.1 
96.9 
97.7 
98.0 
 
100 
100 
100 
100 
100 
 
 (93) 
(245) 
(225) 
(128) 
(102) 
Number of abortions 
  None 
  One or more 
 
3.3 
 2.6  
 
96.7 
97.4 
 
100 
100 
 
(631) 
(158) 
Frequency of husband working away from home 
(past year)  
  Never away 
  One to three times 
  Most of the time 
 
 
2.9 
0.6 
 6.3* 
 
 
97.1 
99.4 
93.7 
 
 
100 
100 
100 
 
 
(391) 
(169) 
(224) 
Husband and wife lived together in past 3 months 
  Yes 
  No 
 
2.8 
 6.5* 
 
97.2 
2.8 
 
100 
100 
 
(641) 
(107) 
Self-reported symptoms 
  Dysuria:  
    Yes 
    No 
  Vaginal discharge:  
    Yes 
    No    
  Vaginal itching:  
    Yes 
    No 
 
 
5.9 
2.9 
 
3.7 
3.3 
 
4.0 
3.2 
 
 
94.1 
97.1 
 
96.3 
96.7 
 
96.0 
96.8 
 
 
100 
100 
 
100 
100 
 
100 
100 
 
 
(102) 
(687) 
 
 (27) 
(764) 
 
 (26) 
(765) 
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  Lower abdominal pain:  
    Yes 
    No 
 
 5.8* 
2.3 
 
94.2 
97.7 
 
100 
100 
 
(224) 
(567) 
LED test on urine 
  High (100 cell/ml) 
  Moderate (75 cell/ml) 
  Trace (10-25 cell/ml) 
  Negative 
 
 5.6* 
--- 
--- 
2.5 
 
94.4 
--- 
--- 
97.5 
 
100 
--- 
--- 
100 
 
(214) 
 (11) 
   (2) 
(558) 
* Chi-square significant at p < .05 
Note: "Number of sexual partners in the past year" and "change of sexual partners in past three months" are not included in table because 99 percent of 
women responded "none" and "no change," respectively, to these questions. 
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 This methodology enabled us to  
determine the number of true cases diagnosed 
by an algorithm based on the four risk factors 
(true positives), the number of women treated 
based on applying the algorithm (true plus false 
positives), its sensitivity (number of cases 
detected/total number of infected women), its 
specificity (number of negative women/total 
number of uninfected women), and its positive 
predictive value (the number of true positives 
diagnosed by the algorithm/number of women 
treated based on applying the algorithm). 
 The results of the application of the  
algorithm are presented in Table 4.  Although 
the model has a sensitivity of 76 percent, its 
specificity is less than 50 percent, and its 
positive predictive value is under 6 percent.  The latter result is particularly important:  in order to 
achieve 76 percent sensitivity, the proportion of the population over-treated by using this algorithm 
is greater than 90 percent.  This level of over-treatment raises ethical questions—through 
treatment of uninfected individuals—and cost questions—in that it uses scarce resources 
unnecessarily.  On the basis of these findings, it has been determined that the algorithm cannot 
be used for screening women for chlamydia in MCH/FP facilities in Thailand. 
 Several risk factors were identified that are significantly related to the prevalence of 
chlamydia.  Their combined effect, however, was almost negligible, with R2 measured through 
multiple regression analysis at only 0.04.  (The R2 measures the proportion variation in the data 
that can be explained by all the risk factors tested in the model.  In this case, the model explains 
less than 4 percent of the variation in prevalence.  In other words, they are unable to account for 
96 percent of the variation in prevalence.)  It is, therefore, unlikely that they would be sufficient, 
along with the other risk factors, to increase the positive predictive value of the algorithm to an 
acceptable level.  It should be noted that, where the prevalence of STDs is higher than in the 
setting studied here, such screening tools may prove to be more useful.  
 
Conclusions 
 The low level of STD prevalence raises questions regarding the practicality of using an 
 
Table 4 
 
Results of the Application of a Score- 
Driven Algorithm for the Screening of 
Women for Chlamydial Infection (pooled 
sample) 
Number of infected women 
diagnosed by laboratory test 
25 
Number of true cases diagnosed by 
algorithm (true positives) 
19 
Number of women treated following 
application of algorithm (true plus 
false positives) 
347 
Sensitivity (%) 76.0 
Specificity (%) 46.8 
Positive predictive value (%) 5.5 
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algorithm to diagnose STDs among women attending MCH/FP facilities in the Thai context.  Even 
if the screening tool had a sensitivity and a positive predictive value of 100 percent, it would only 
identify four cases out of each 100 attendees, which would not justify the time and effort involved 
in employing it.  As an alternative, an intervention that integrates STD education, referral, and self-
assessment of risk into MCH/FP programs should be investigated.  This could be accomplished 
through training programs for health promotion officers, who are clinic based, and village health 
volunteers, who are based in the community.  Such a training program would consist of the 
following: 
 · Training health promotion officers to improve their knowledge about STD/HIV 
prevention and their ability to communicate this knowledge, and informing  women 
who attend clinics on where STD services can be obtained (referral).  
 
 · Training for village health volunteers to improve their knowledge about STD/HIV 
prevention and services and ways to communicate this knowledge during home visits 
and group meetings, and educating women on how to assess their own risk of 
STD/HIV, based on conventional risk factors and those identified in the study. 
 
 The intervention would also include the provision of information on STD/HIV prevention 
and location of STD services within the information, education, and communication (IEC) 
component of the MCH/FP program. 
 
DISCUSSANTS  
Huda Zurayk 
The Population Council 
Cairo, Egypt 
 
 When we began the Giza study on which I reported earlier, we were interested in 
women's reports related to the presence of reproductive tract infections (RTIs) or symptoms 
indicating their presence.  We were not only attempting to determine whether or not algorithms 
were useful for screening, but also to determine the magnitude of the problem in the community.  
The study was conducted in a small community; because of its cost, it could not be replicated on a 
larger scale.  One of the objectives of this study was to learn the extent to which women's reports 
of symptoms, compared to medical exams, could give us an estimate of the prevalence of 
gynecological conditions including RTIs.  
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 Our work involved the use of a 
number of methods.  Seventy-seven 
percent of the women reported 
discharge, but only 13 percent of the 
women considered it "not their nature," 
that is, suspicious to the women.  The 
women reported characteristics of the 
discharge they were experiencing in 
terms of color, odor, consistency, and 
accompanying itching.  When these 
were analyzed, 63 percent of the women 
were considered to have medically 
suspicious discharge.  By comparison, 
the examining physicians observed 
discharge in 83 percent of women.  We also asked an independent team of three physicians to 
review the women's reported symptoms from the interview alone, and to review these reports in 
combination with the medical exam sheets.  In the former case, they determined that 61 percent 
of the women had RTIs; in the latter case, the figure rose to 70 percent.  In both cases, physicians 
overestimated the problem.  However, as an estimate of magnitude of the problem of RTIs, all 
methods pointed to its gravity, except women's perceptions of the seriousness of the discharge.  
When we tried to examine the agreement for each woman's report of discharge with the physician 
observation, we found poor correlation between the woman's report and medical diagnosis.  
Women's reports of discharge were thus shown not to be predictive of the occurrence of RTI. 
 We then tried to determine whether these results might relate to the fact that the women 
did not know what to look for in terms of symptoms and/or to their behavior prior to having clinical 
exams.  We had asked them to refrain from washing prior to going to the clinic so that if they had 
reported discharge the physician would be able to observe it.  Despite our request, however, 
many probably did wash before the exam, which is common practice. 
 Do we give up asking about women's perceptions of their symptoms since we know they 
are not predictive medically?  Can we, through surveys, get some idea of the conditions women 
have?  It is important—from the point of view of learning about women's experiences— to 
determine whether women have discharge or other symptoms, and what they consider to be 
serious.  These reports can be used as a community assessment of the magnitude of the problem 
and are indicative of the perceptions of women and their health-seeking behavior related to 
Table 1 
 
Prevalence of Reproductive Tract Infections (RTIs) Using 
Various Diagnostic Methods 
 % 
Presence of discharge by clinical examination 83 
Medically diagnosed RTI (lab tests) 51 
Women's report of discharge 
  Presence 
  Suspicious to woman 
  Suspicious medically 
 
77 
13 
63 
Diagnosis of RTI based on review by physician of: 
  Interview questionnaire 
  Clinical exam sheet and questionnaire 
 
61 
70 
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symptoms of RTIs. 
 
 
 
 
 
Inne Susanti 
University of Udayana 
School of Medicine, Pathology Department 
Denpasar, Bali, Indonesia 
 
 I plan to discuss the utility of algorithms and risk screening based on a study of 
reproductive tract infections (RTIs) in Bali.  The objective of the study, which was cross-sectional 
in design, was to determine the prevalence and range of RTIs among women presenting at clinics 
for menstrual regulation and to develop a simple and inexpensive approach for RTI detection.  
The information we collected was similar to that described by Dr. Thongkrajai, and the same 
questions were asked about discharge and other symptoms.  We also conducted speculum 
exams and laboratory tests, and took vaginal specimens (for a potassium hydroxide (KOH) odor 
test, pH test, wet mount culture, and gram stain), blood samples (for syphilis and HIV tests), and 
cervical samples (for chlamydia testing, Pap smear, and swab test).   
 We tried to determine risk levels from the demographic information collected using the 
questionnaires and compared these with the clinical data, but they did not correspond.  We found 
that the algorithms were not predictive.  As such, it is essential that more thought and discussion 
be devoted to the use of algorithms for RTI management. 
 
Discussion 
 Christopher Elias:  We should move away from the term "algorithm" because the word 
means different things to different people.  We need to discuss two different issues:  case 
management, on the one hand, and case finding, on the other.  There are different ways to 
conduct case finding.  The best is to use expensive diagnostic tests in a rationed manner, 
perhaps with high-risk populations:  this has been done in the U.S. and Australia by testing 
adolescents, because we know they are at greater risk of having infections and that the 
consequences are particularly serious for this group, indicating that it may be wisest to focus ex-
tremely scarce resources in this way.  We need to determine if screening by other means, such as 
risk scoring, has any utility.  At the same time, and most importantly, we need to invest in better 
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and cheaper diagnostic technology.   
 Beverly Winikoff:  We have to examine the fact that one of every two women who are 
determined by risk screening to have an RTI does not have an infection.  What are the 
consequences for that woman of being labeled in this way?  What are the risks to people of being 
labeled positive or negatively falsely, and to which of these risk are we most averse?  What is the 
response to a positive diagnosis?  In resource-constrained environments, are people being 
treated for infections they do not have?  These and other important questions must be explored. 
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BUILDING THE COALITIONS NEEDED TO ADDRESS RTIS:  
SERVICE PROVIDERS, POLICYMAKERS, COMMUNITIES 
 
Nguyen Kim Cuc 
Vietnam Women's Union 
Hanoi, Vietnam 
 
 Vaginal and cervical problems are common in Vietnam and have serious implications for 
the health of women and their families, especially through their potential impact on fertility.  The 
prevalence of reproductive tract infections (RTIs) among women of reproductive age in Vietnam is 
approximately 50 percent, and as high as 80 percent in some provinces.  Vaginitis and cervical 
infection are extremely common, affecting about 90 percent of women of reproductive age. 
 In the past, Vietnamese women, and particularly those in rural areas, used traditional 
medicine for RTIs and rarely sought help from the formal health care system.  In recent years, 
however, the latter system has been strengthened and many more women now utilize its services. 
 Unfortunately, many women in remote rural areas lack access to the services that urban women 
enjoy.  As a result, the Vietnam Women's Union has made women's health care a priority.  We 
believe that "Health is wealth," and have organized medical check-ups and consultations for 
women, as well as family planning education campaigns.  The Union, which works in collaboration 
with the Ministry of Health and a number of provincial health services, has also conducted surveys 
to determine the causes of RTIs and, based on these findings, is developing intervention 
strategies. 
 
Survey findings reveal the following: 
 
 · poor knowledge of hygiene in general, and of menstrual and sexual hygiene in 
particular; 
 
 · lack of safe water and poor sanitation; and 
 
 · poor medical services, including unsafe intrauterine device (IUD) insertion, abortion, 
and menstrual regulation. 
 
 Based on the incidence of RTIs and their root causes, some of which are mentioned 
above, the Vietnam Women's Union realized that the problem could not be addressed effectively 
unless a strong coalition was built among a wide range of institutions, including the Ministry of 
Health, the Ministry of Labor—which is responsible for the water supply program— and the War 
Invalid and Social Affairs and Youth Union, which is responsible for education on sanitation.  
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Through this coalition, which began work in 1992, we hope to succeed in our efforts to reduce the 
incidence of RTIs.     
 
Inne Susanti 
University of Udayana 
School of Medicine, Pathology Department 
Denpasar, Bali, Indonesia 
 
    About 70 percent of the women surveyed in the study I described earlier had experi-
enced vaginal discharge; most of the women had also experienced itching and most did not 
realize that these could be symptoms of a problem.  Many women think that vaginal discharge is 
caused by stress, certain foods, or poor hygiene.  In addition, some women use oral and vaginal 
preparations that affect reproductive tract infections (RTIs), including vaginal tightening agents for 
sexual intercourse.  Women reported that they were unsatisfied with the information they received 
from health care providers when they did inquire about their symptoms; indeed, many indicated 
that doctors and other providers told them that discharge was no cause for concern.   
 We learned from women and from discussions with doctors and midwives that informa-
tion about RTIs is scarce.  Health care providers reported that the reason they did not conduct 
clinical examinations to test for RTIs is that the women they treat are modest and do not want to 
be examined by male doctors.  In addition, doctors said they were hesitant to discuss the possi-
bility that a woman might have a sexually transmitted infection because they did not want to 
disrupt her family life.  In most cases, therefore, no vaginal specimens are taken.  Almost all of the 
midwives and doctors interviewed reported that they make a diagnosis on the basis of the symp-
toms that a woman describes.   The most common diagnosis made on this basis is candida.  
 The problem of RTIs has never been so urgent.  As such, it is more important than ever 
that we overcome the obstacles to dealing with the problem, collaborate, form coalitions, and dis-
seminate information about the prevention and treatment of RTIs.  Possible steps include 
providing more training and information to health care providers, increasing program and policy 
focus in this area, setting up mobile clinics for RTI screening, and establishing interdisciplinary 
coalitions to address and research RTIs.   
 
 
 
 
Nicola Jones 
The Ford Foundation 
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Manila, Philippines 
 
 There are three questions we might ask regarding coalition building around reproductive 
tract infections (RTIs): 
 1.  Why do we need coalitions? 
 
 2.  What are the obstacles to coalition building? 
 
 3.  How do we overcome these obstacles?  
 We need coalitions for a variety of important reasons.  Participants in a recent HIV/AIDS 
and Development Awareness Seminar Workshop in the Philippines, for example, suggested that 
these include: opportunities to improve skills, coordination and support, facilitating referrals, 
maximizing existing resources, and a wide range of other factors. 
 
Why do we need coalitions? 
 As we have discussed during this meeting, RTIs are rarely perceived to be a problem—
even by those who suffer from them.  Unlike AIDS, they are a "silent emergency."  Coalitions can 
help place RTIs higher on the public health agenda.  I believe that a multi-sectoral approach is es-
sential in this regard:  RTIs are not simply a medical problem—they also have social, cultural, 
moral, economic, and political implications.   
 My experience in supporting coalitions suggests that while it is helpful to have as wide a 
membership as possible, numbers do not guarantee success.  For RTIs to gain public attention, 
members must be driven by their own interest in, commitment to, and preferably passion for the 
issue—and not commandeered as representatives of a particular agency.  They must also have 
access to accurate, local information.  Research coalitions, in the form of participatory and inter-
disciplinary research programs, have a crucial role to play in identifying the issues and mobilizing 
action.   
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  Donors—and particularly private 
donors—are in a very privileged position in 
the area of coalition building, and have much 
to gain from them.  Coalitions maximize the 
use of limited resources, generate energy, 
and achieve an impact that would not be 
possible with individual partners.  
 
What are the obstacles to coalition 
building? 
 For coalitions to work effectively, 
members must understand and respect the 
contributions of those who represent different 
organizations or perspectives and share 
common principles and goals.  There are several factors that work against open and equal 
partnerships.  Non-governmental organizations (NGOs), for example, are often wary of working 
with governments.  Physicians and lawyers rarely feel challenged by others, particularly by poor 
women.  Feminist organizations from capital cities do not have close ties with grassroots women's 
organizations, which are rarely well organized.  Many policymakers are uncomfortable with issues 
related to sexuality and reproductive health.  Conservative religious views often conflict with 
women-centered approaches to these issues.  
 
How do we overcome these obstacles? 
 In order to overcome these and other obstacles, the Ford Foundation in the Philippines is 
developing partnerships around the issues of sexual and reproductive health.  We encourage 
interdisciplinary and multi-sectoral programs to research and address RTIs, in order to bring activ-
ists from a wide variety of backgrounds together to work effectively on the issues surrounding 
RTIs.  We support national and regional working groups, the establishment of an interagency 
advisory committee to the government's Commission on Population to help develop an agenda 
that is sensitive to reproductive health concerns, and the development of an interdisciplinary 
diploma and a Masters level health/social science program on gender, sexuality, and reproductive 
health to train new professionals in the field.  We are still in our first phase of combat against 
RTIs, but we recognize that encouraging communication and interaction among the full range of 
partners will be essential to the development of a successful national RTI prevention and 
 
 Obstacles to Coalition Building 
 
 · Status and power of physicians and lawyers 
 ·  Misunderstandings between medical, bio-
medical, and social scientists 
 · Uneasy relationship between NGOs and 
government agencies 
 ·  Few NGOs are interested in health 
 · Many feminist NGOs are in capital cities 
 · Provincial grassroots women are often not 
organized and not linked with urban feminist 
NGOs 
 · Policymakers' negative attitudes 
 · Decentralization of responsibility for many 
services to local governments, with 
commensurate central government loss of 
implementing power  
 · Religion and cultural values  
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treatment program. 
 In order to develop appropriate responses to RTIs, we also need to involve women and 
men in research and action programs.  By encouraging active partnerships among communities 
and NGOs, universities, modern and traditional practitioners, and government agencies, we 
should ensure that the expanding knowledge base is systematically linked to policy and program 
development.   
 An often neglected factor in building and sustaining coalitions is having fun.  During the 
last afternoon of a recent conference, participants celebrated with parlor games, dancing, prayers, 
and community singing.  This kind of social interaction is crucial to bringing and keeping people 
together to work toward a common cause.   
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 IMPACT ASSESSMENT: WHAT CRITERIA DO WE USE TO DEMONSTRATE 
 THE IMPORTANCE OF RTIS TO POLICYMAKERS? 
Ana Langer 
The Population Council 
Mexico City, Mexico 
 
 Currently, there is agreement among international agencies on the importance of 
addressing sexually transmitted diseases (STDs) in the developing world and on the need to 
integrate STD management with other reproductive health services.  Theoretically, merging 
vertical programs and services—such as maternal and child health (MCH), family planning, and 
STD services—should have a synergistic, positive effect on women's health.  In spite of this 
increasing consensus, however, strong skepticism arises among public health policymakers, 
program managers, health care providers, and donors when it comes to investing resources in 
this area.  The following questions arise, which I plan to address in turn.  Is it really necessary to 
address STDs?  Are STD control programs cost-effective?  Can the impact of STD control 
activities be measured?  Is it feasible to implement all the services necessary to ensure that an 
STD control program is effective?   
 
Is it really necessary to address STDs? 
 It is not uncommon to hear that STDs do not deserve the attention that international 
agencies are encouraging.  Two main arguments, which are not based on true and objective 
information, are usually made to support this view. 
 STD prevalence is low among the general population   Unfortunately, data on STD 
prevalence among the general population is very scarce.  Only approximate figures can be 
obtained, based on women attending general, prenatal, or family planning clinics (Brunham and 
Embree, 1992; Donoso, et al., 1984; Faundes and Tanaka, 1992; Alvarez, et al., 1992; Weström 
and Mardh, 1984).  These studies have found rather high prevalence rates for chlamydia, 
trichomonas, and, in some contexts, gonorrhea.  There are, however, almost no population-based 
studies or studies of women who do not use these services.  This information is urgently needed 
to assess the public health importance of the problem and to develop control and treatment 
strategies adapted to each context, since the STD epidemiology varies from country to country. 
 STDs are not fatal  There is sufficient evidence of the devastating effects of reproductive 
tract infections (RTIs) and STDs on women's and infants' health (Weström, 1980; Weström, et al., 
1981; Franco, 1991; Reeves, et al., 1989; Wasserheit, 1990).  Pelvic inflammatory disease (PID), 
infertility, ectopic pregnancy, cervical cancer, increased risk of acquiring HIV/AIDS, fetal wastage, 
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low birthweight, and neonatal blindness are among these effects, and there are others. 
Dissemination of information about the complications of these preventable and treatable diseases 
should be more aggressive.  Evaluating health care providers' awareness of the importance of 
STDs and their consequences should also be made a priority. 
 
Are STD control programs cost-effective? 
 Data on the economic burden of STDs in the developing world, as well as the resources 
available and needed for their prevention and control, are very scarce.  Most of the few existing 
studies are simulations.  The World Bank (1993) has suggested a strategy for measuring the 
cost-effectiveness of health interventions, through which different interventions are compared in 
terms of the cost of achieving one additional year of healthy life.  Outcomes are measured using 
disability-adjusted life-years (DALYs), which are also used to estimate the burden of disease.  The 
unit cost of an additional DALY is the measure of an intervention's cost-effectiveness; the lower 
the number, the greater the value for money offered by the intervention.    
 Among communicable, maternal, and perinatal illnesses, the World Bank ranks STDs, 
excluding AIDS, third in terms of women's disease burden.  In the list of priority health 
interventions, STDs rank second, following pregnancy-related illnesses, and are categorized as 
diseases that can, to a large extent, be controlled using cost-effective interventions (less than 
$100 per DALY saved).  The importance of STDs in terms of their contribution to the disease 
burden and the availability of effective and inexpensive interventions led the World Bank to 
recommend STD-related interventions as a component of a minimum package of care.   
 The limitations of the World Bank strategy include the fact that cost-effectiveness 
estimates were not calculated separately for each STD and that obstacles related to work in the 
field were not considered.  For instance, screening for chlamydia may be less cost-effective than 
for syphilis, and the ratio varies according to local prevalence.  In addition, availability of drugs, 
equipment, laboratory facilities, and so forth, would also modify the cost-effectiveness in different 
contexts.    
 Only a small proportion of the thousands of STD-related interventions were analyzed 
using the methodology described above.  Among them, interventions for preventing congenital 
syphilis have a favorable cost-effectiveness ratio.  Because syphilis treatment is simple and 
affordable, screening and treatment during the prenatal period has been widely recommended. 
Other studies have found that eye prophylaxis at birth to prevent gonococcal ophthalmia 
neonatorum is much less expensive than treating the cases themselves (Laga, et al., 1989), even 
at maternal gonorrhea prevalence rates of less than 1 percent.  These activities have a favorable 
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cost-effectiveness ratio in both developed and developing countries (Stray-Pedersen, 1983).  
Effective interventions exist for other STDs, but the lack of simple, appropriate, rapid, and 
inexpensive diagnostics for use in the field render these measures much more difficult and 
expensive to implement.  Consequently, when resources are limited, such interventions should be 
targeted specifically to high-prevalence groups in order to be cost-effective.  Estimates suggest 
that if the prevalence of an STD is greater than 10 percent, treating everyone in the risk group 
may be more cost-effective than screening, especially when laboratory facilities are not available 
or are insufficient (Piot and Rowley, 1992).  
 Using a different methodology—cost per case averted—Shulz and colleagues (1992) 
compared the seriousness of the problems conventional STDs cause to infants to that of the 
infectious diseases currently addressed by international donor agencies (tetanus, polio, measles, 
and pertussis).  The authors concluded that the problems caused by STDs are at least as serious 
as those caused by immunizable diseases, and the interventions to deal with them seem to be 
more cost-effective.  Indeed, if benefits to women were included, this would improve the 
cost-effectiveness ratio of the interventions even further.  This hypothesis, and the World Bank 
approach described above, need to be field-tested to increase the likelihood that they will 
influence decisionmaking. 
 Piot and Rowley (1992) contributed to highlighting the economic burden of STDs by 
reviewing the information available on the direct and indirect costs of the management of STDs 
and their sequelae in developing countries.  The authors calculated the direct costs of different 
screening procedures and concluded that while clinical diagnosis is the least expensive and most 
rapid, it is also the least sensitive and specific.  They also pointed out that no data on the costs of 
managing the complications and sequelae of STDs are available; however, these costs would 
certainly be higher than those of controlling the infections.  Over and Piot (1991) estimated the 
indirect costs of STDs and the benefits of preventing them (using discounted healthy life-years) in 
an urban area in Africa with high STD prevalence.  According to their calculations, preventing 
STDs results in considerable improvements in health.  Their indirect cost calculations do not, 
however, encompass the impact of STDs on infant morbidity and mortality nor the social and 
economic consequences of STD-related morbidity or mortality.  Finally, Piot and Rowley (1992) 
synthesized the scarce information available about the effectiveness and costs of STD 
interventions.  They stressed that each case of STD prevented will also prevent additional cases.  
It is not, therefore, sufficient to compare the benefits of preventing a single case to the cost of the 
activities necessary to do so; the benefits to individuals other than those immediately affected 
must also be considered.  Analyses of the cost-effectiveness of behavioral interventions for the 
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prevention of STDs have not been carried out.  Condom promotion activities, and especially social 
marketing as opposed to free distribution, seem, however, to be successful.  
 Experts in health economics generally agree on the need to generate more empirical 
evidence about the economic impact of STDs.  This information is essential to combatting existing 
skepticism.  Gross cost-effectiveness estimates may not be enough to convince program 
managers, public health decisionmakers, and providers that the interventions are worthwhile, 
given competing priorities for resources and the logistical difficulties associated with work in this 
area.  While an efficacy study may show that an intervention can work, an effectiveness 
evaluation showing that it works outside of the research milieu and an efficiency study showing 
that it is worthwhile and feasible are essential prior to widespread introduction of the intervention 
(Ronald and Aral, 1992). 
 
Can the impact of STD control activities be measured? 
 The main goal of any intervention is to ameliorate the health problem it intends to 
address.  To demonstrate impact, and before an intervention can be considered for widespread 
implementation, a well-designed and methodologically sound evaluation is required.  The validity 
of the scientific evidence for an intervention can be considered proven when it has shown positive 
effects following a prospective, randomized, controlled, and community-based study.  This is a 
very high standard, extremely difficult to achieve (Ronald and Aral, 1992).   Quasi-experimental 
designs are an acceptable alternative when comparability among experimental and control sites is 
adequate and all relevant variables that need to be controlled for in the analysis are measured; 
both conditions are necessary to ensure that such studies have sound internal validity.  Scientific 
evidence of impact can be categorized as tentative when it comes from uncontrolled, 
non-randomized, and often retrospective—or "before and after"—studies.  Most evaluations of 
STD interventions fall into this category.  The positive effects of an intervention can only be 
considered as assumed when there is no scientific evidence, but experts in the field think of it as 
worthwhile (Ronald and Aral, 1992). 
 In addition to appropriate research design, demonstrating impact requires accurate 
identification of the outcomes to be measured.  The development of a careful conceptual 
framework based on current scientific knowledge during the preparation phase of an evaluation 
usually helps in this regard.  Two types of impact outcomes—intermediate and final—can be 
measured.  The type chosen will depend on the nature of the intervention being evaluated.  The 
following example will help clarify this concept.  The effects of an intervention consisting of 
lectures and radio campaigns to promote the use of condoms, for instance, was estimated by 
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measuring changes in the awareness of the condom as a method of AIDS and STD prevention 
(intermediate outcome) and by actual changes in overall condom use as a prophylactic measure 
(final outcome) (Vernon, et al., 1990).  Impact outcomes, whether intermediate or final, must be 
consistent with the goals of the intervention under evaluation.  The impact of an intervention 
consisting of screening, diagnosing, and treating gonococcal infection during pregnancy, for 
example, would be based on changes in three different outcomes:  the incidence of prematurity, 
neonatal ophthalmia, and postpartum endometritis.   
 There are also both impact and process outcomes.  For an intervention consisting of the 
establishment of STD control services in a family planning clinic, the impact outcomes could be 
the prevalence of certain infectious agents among clinic users or the frequency of PID after 
intrauterine device (IUD) insertion.  Both should be lower after the intervention is established, or 
lower than among users of a similar clinic.  If the resources needed to complete a prevalence 
study are not available, or if patient follow-up is too difficult, process outcomes, such as the 
inclusion of information, education, and communication (IEC) about STDs in the clinic's routine 
practice or the number of lab tests performed, could also be used to demonstrate changes 
attributable to the intervention.   
 After identifying the outcomes that will allow the effects of an intervention to be 
demonstrated, researchers must be sure they have all the elements they need to measure these 
effects correctly.  They must also develop adequate instruments to collect data and train people to 
do so.  Attention to these issues is crucial if valid results are to be obtained. 
 
Is it feasible to implement all the services necessary to ensure that an STD control 
program is effective? 
 Finally, feasibility also generates skepticism, and the list of requirements for establishing a 
comprehensive STD control program makes this understandable.  What must STD programs do 
in order to be effective? (Population Reports, 1993) 
 
 · Develop overall strategies based on health care resources and disease prevalence 
patterns 
 
 ·  Develop effective services in primary health clinics 
 
 ·  Train and equip STD service providers to diagnose and treat patients in one visit 
 
 ·  Ensure a reliable supply of condoms and drugs to treat STDs 
 
 ·  Make good STD counseling a high priority 
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 · Strengthen STD training in medical, nursing, midwifery, and other health professional 
schools 
 
 · Provide in-service training for primary health care providers 
 
 · Involve private practitioners—pharmacists, private doctors, midwives, and so forth 
 
 · Conduct mass media campaigns and in-clinic programs to encourage people to 
recognize STDs, seek treatment, and use condoms 
 
 · Conduct surveillance to identify the most prevalent STDs and drug resistance to STDs 
 
 · Set up syphilis screening programs in antenatal clinics 
 
 · Set up special programs for high-risk populations 
 
 · Make sure that the sexual partners of STD patients are treated 
 
 · Combine STD and AIDS programs 
 
 Women have a right to obtain the care they need for their health problems, and 
professionals, researchers, and activists working in the women's health field have a duty to help 
meet those needs.  Skepticism is sometimes authentic, but it can also be an expression of 
awareness of the difficulties and severe constraints we face in the developing world.  Research on 
STDs has not yet provided enough information to overcome the skepticism; given the significance 
of the problem and the magnitude of the obstacles to overcoming it, investment in such research 
is warranted.  Each component of an STD program requires epidemiologic, health system, social, 
and economic research before it can be implemented with confidence.  Demonstration projects to 
evaluate comprehensive programs involving most of the components listed above are also 
necessary.  
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 How do those of us working primarily in research convince those who are skeptical to pay 
more attention and allocate more funds to the prevention and treatment of reproductive tract 
infections (RTIs)?  Who are the skeptics?  They are donors, politicians, and health and family 
planning program managers; these are key strategic groups, although there are skeptics in other 
groups as well—including service providers, some advocacy groups, and some researchers 
themselves, who all demand different levels of proof that RTIs are a serious problem with cost-
effective solutions. 
 
Donors 
 Donors ask, "What is an RTI?" and "Why should we pay attention to RTIs when there are 
women dying in childbirth, or when population growth is undermining development?"  It is our job 
to raise their awareness of the consequences of RTIs; link RTI interventions to their priority 
programs, including Safe Motherhood and HIV programs; look for specific opportunities to 
improve service delivery related to RTIs, for example including RTIs in a project to upgrade 
laboratories or develop training curricula; and collaborate with Women in Development programs 
that are already working to integrate gender issues into other program areas. 
 
Politicians 
 Politicians say, "RTIs cannot happen in my country—we do not have these kinds of 
problems," "Our religion prohibits prostitution so we do not have RTIs/STDs," and "Those 
international statistics you cite are not relevant here."  In order to convince politicians to pay 
attention and channel scarce resources to RTI prevention and treatment, we need to: 
 
 • be proactive, by providing them with relevant information from the local context; 
 
 • acknowledge limits of global statistics, but stress global commitments to reproductive 
health; 
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 • acknowledge and explain the links between RTIs and behavior, and explain that not all 
RTIs are sexually transmitted; and 
 
 • accentuate the positive, by giving politicians the good news about successful pilot 
projects. 
 
Family planning managers 
 Family planning managers say, "My task is to bring down the birth rate—women's health 
is another department's responsibility."  In order to convince them of the importance of RTIs to 
their own work, we need to provide them with evidence from studies that reveal that linking RTI 
services with family planning programs has no negative effect on contraceptive service provision.  
We need cost studies comparing stand-alone family planning services with various levels of 
integrated services.  We should also emphasize the influence that RTIs have on safe delivery and 
use—and continuation of use—of contraceptives. 
 
Health program managers 
 Health program managers say, "We are already doing this kind of work" or conversely 
"We cannot afford to do this kind of work."  To meet these arguments, we must do the following: 
 
 • provide them with evidence of the costs and limitations of existing programs, such as 
single-purpose STD clinics; 
 
 • help them to improve the RTI prevention and treatment services that are in place; and  
 
 • again, provide them with good news related to pilot projects. 
 
 In order to convince the skeptics to focus on RTIs, we need to provide them with 
information on the consequences of underdiagnosed and untreated RTIs, and illustrate the 
possibilities for integrating RTI interventions with existing programs, tailoring our approach 
strategically to the range of skeptics who make up our audience. 
 
Joan Kaufman 
Abt Associates, Inc. 
Cambridge, Massachusetts 
 
 
 I would like to make a few comments about ways to convince policymakers to pay 
attention to reproductive tract infections (RTIs).  RTIs have been a problem for a very long time.  
There are early studies from India that suggest they were identified as a problem 10–15 years 
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ago.  A variety of studies, however, suggest that in many settings provider attitudes have impeded 
appropriate management of RTIs.  Providers often consider vaginal discharge to be normal, and 
have not paid attention to abnormal discharge.  RTIs have only gained the attention of 
policymakers because of the new focus on sexually transmitted diseases (STDs), which has 
stemmed from the AIDS epidemic.  However, much of the attention has been focused on 
symptomatic STDs in high-risk populations.  Little attention has been paid to RTIs in the general 
population of women; RTIs are the neglected "half-sister" of STDs in men.   
 In order to change this situation, we must try to provide information on the consequences 
of untreated RTIs in ways that matter to policymakers.  Unfortunately, some of the early work on 
RTIs was faulty in terms of its methodology and did not help in this regard.  In my opinion, we 
need to document and convey the fact that RTIs cause significant morbidity if not diagnosed and 
treated early.  This is difficult, however, because many women with RTIs do not seek care for 
related problems. 
 The obvious major consequence of RTIs—infertility—can result in social stigma and other 
negative social consequences.  In Africa, infertile women are frequently abandoned by their 
husbands and then migrate to cities; they may resort to prostitution and, as a result, contribute to 
urban health problems.  Placing infertility in a larger social context, and documenting its costs, 
may be of use in drawing policymakers' attention to the problem.     
 The adverse birth outcomes and impact on offspring that may result from RTIs, including 
pregnancy loss, premature births, and low birthweight infants, should also be pointed out to 
policymakers.  These problems could be prevented, in part, through diagnosis and treatment of 
infection during antenatal care provision.   
 Underdiagnosed RTIs also play a role in human immunodeficiency virus (HIV) 
transmission. In addition, the incidence of human papilloma virus (HPV) is related to cervical 
cancer rates.  These facts should also be conveyed to policymakers more effectively to 
underscore the importance of early intervention. 
  We also need to do a better job of documenting the indirect effects of morbidity related to 
RTIs, such as the effect of pelvic pain and other symptoms which negatively affect women's ability 
to work.  This type of economic analysis is difficult, but can be very convincing to policymakers. 
 The main task ahead is to document, to whatever degree we can, the impact of RTIs on 
women in terms of measurable and self-perceived morbidity.  If we succeed in doing so, 
policymakers may be convinced to allocate more funding to prevention, early screening, and 
treatment.   
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 LESSONS LEARNED FROM RESEARCH ON RTIS: 
 SUMMARIZING THE OBSTACLES ENCOUNTERED 
Valerie Hull 
The Population Council 
Jakarta, Indonesia 
 
 This presentation discusses the main obstacles related to research, dissemination, 
programming, and policy change in the field of reproductive tract infections (RTIs), as well as 
possible priorities for our work and ways of overcoming the obstacles we face. 
 
General obstacles 
 A range of general obstacles underlie all work related to RTI research, policy, and 
programming.  There is an overall lack of awareness of the problem and a resistance to 
acknowledging and learning more about it.  Misperceptions and moralistic denial are found at the 
individual, community, program, and political levels.  Yesterday, for example, we heard that the 
Chinese government had claimed to have eradicated sexually transmitted diseases (STDs) in 
China; research in sensitive areas can be interpreted as defying both moral order and legitimate 
authority.  Women's position in society represents an additional, overriding obstacle, and relates 
primarily to their limited negotiating power in all spheres—from sexual relations to client-provider 
interactions to the policymaking arena.  Poor quality of care also underlies the more specific 
obstacles we face:  poor provider attitudes, training, management, and systems are formidable 
obstacles to reform.  Resource constraints and allocation limit the quantity and quality of services; 
in some areas, resources are simply not available, and in others, health in general, and women's 
health in particular, receive a disproportionately low share of available funds.  The general lack of 
resources, particularly among women, is also an obstacle because as we have heard, poverty 
underlies many of the causes of RTIs. 
 
Developing research 
 Obstacles related to developing research can be divided into several categories.  Set-ting 
relevant local priorities is critical, but is often problematic due to a lack of dialogue with or direct 
input from community members and a lack of alliances between researchers and service 
providers.  We have heard a great deal about the importance of getting feedback from and in-
volving family planning and health service providers and professional associations in research so 
that they will feel a sense of ownership.  Despite our efforts, there is also lack of dialogue between 
researchers and policymakers and between local and international research communities. 
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 The lack of an international 
coordinating agency hinders our efforts to 
set global priorities, although the World 
Health Organization (WHO) STD 
Diagnostics Initiative and Human 
Reproduction Programme (HRP) can play 
this role to some extent.  The lack of local 
research coordination is problematic to all 
research, not only research that pertains 
to RTIs.  Avoiding duplication and 
maximizing research efforts is rare, and 
sometimes reaches appalling levels, 
wasting the limited resources we have 
available.  Unfortunately, overcoming this obstacle is probably a pipe dream; most researchers do 
not want to be "coordinated."  In many settings, the capacity of researchers is limited, both in 
terms of their general background and their training in specific research techniques. 
 There are numerous examples of 
possible local and global priorities and 
research populations (see boxes), which 
demonstrates how difficult it can be to 
choose from among them.  We are 
presented with many potentially valuable 
research ideas, but decisions among 
them must be made.  
 
Conducting research 
 The capacity of researchers is also relevant to conducting research.  We are calling, for 
example, for more qualitative research, and in many countries there is a strong cadre of trained 
survey researchers now trying to come to grips with these new approaches.  It takes some extra 
training and reorientation to achieve rigorous qualitative research.  Without this rigor, "qualitative 
research" is really journalism, and maybe not even good journalism.  More women need to be 
involved in research and more researchers with the capacity to establish rapport with female 
participants must be involved in related efforts.  Weak laboratory support facilities are an obstacle 
to conducting research in many settings.  Respondent sensitivity is also said to be an obstacle by 
 Possible local priorities 
 
.  secondary research 
.  epidemiological studies 
.  qualitative research 
.  interventions 
.  other Operations Research 
.  other "special purpose" 
 .  antibiotic resistance 
 .  antibiotic prophylaxis for IUDs 
.   RTI-relevant social and health research 
 .  sexuality 
 .  gender relations 
 .  ethnomedicine 
 .  health service utilization  
 Possible global priorities 
 
.  management guidelines 
.  microbicides and female-controlled methods 
.  inexpensive diagnostics 
.  vaccine research  
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health department officials, interviewers, or university-educated local researchers, but does not 
always prove to be a problem.  Often, when you gather women in a room in an atmosphere that is 
conducive to discussing these issues, they have a great deal to say.  As such, we are faced with 
"gatekeeper reluctance"; that is, it is often the educated elite who are more sensitive than the 
respondents.  Finally, there are the ethical issues.  What is the effect on informants of gathering 
information on these issues?  What are the ethics of research that does not have an intervention 
component? 
 
Interpreting research results 
 The critical ability of researchers influences their capacity to interpret research results.  So 
often we see research reports that are primarily descriptive, rather than analytical or action-
oriented.  This analytical capacity must be developed.  Lack of familiarity with qualitative research, 
and especially the analysis of qualitative research, comes up again here.  Even if researchers are 
able to conduct focus group discussions, for example, rigorous analysis of the results is often a 
problem.  Finally, there are inherent problems of measurement in the area of RTI research, 
including the whole area of quality control of diagnostics and the proper conduct of impact studies, 
which can be difficult in any field. 
 
Disseminating research results  
 The writing skills of researchers is an obstacle that hinders the effective dissemination of 
research results.  Researchers often do not present results in a way that is tailored to particular 
audiences, especially policymakers.  They often do not establish links with the media or write for 
popular publications.  Women's magazines in Indonesia, for example, are crying out for articles on 
women's health.  If researchers were able to provide locally relevant, well- written reports, the 
impact of research results would be enhanced.  The lack of a reading culture, however, applies in 
some settings, including Indonesia.  Making reports readable and interesting, and presenting 
results through audiovisual means may help combat this obstacle.  One implication of a lack of 
research coordination that is also problematic is that research reports become part of the 
(sometimes permanently) 'fugitive literature.'  Finally, there is the moral climate or censorship of 
research results, which operates on two levels.  First, there is a certain degree of self-censorship 
among academics.  In Indonesia, for example, researchers avoid sensitive research topics, or do 
not report findings that are critical of government programs.  Second, there can be outright 
censorship by authorities of critical reports. 
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Developing and proposing interventions 
 I have divided interventions into six areas:  education, preventive efforts, detection, 
treatment, technical/biomedical, and programmatic. 
 The needs for education are enormous.  We have only limited knowledge of local terms 
and perceptions related to RTIs, which presents an obstacle to developing effective interventions. 
 There is also a lack of tested educational approaches, in terms of both message content and 
appropriate media.  Lessons have been learned from other health promotion efforts and, perhaps, 
from approaches that are being tested in the HIV field, but we will nonetheless need to test 
approaches that are specific to RTIs.  Due to a lack of basic sex and reproductive health 
education, women lack knowledge of their bodies.  Messages related to RTIs may need to begin 
at a very basic level.  Developing appropriate messages for client self-assessment of risk, a 
subject we discussed earlier, is also an obstacle insofar as, again, there is much we do not know 
about message content and delivery. 
 Obstacles to preventive efforts other than education relate to the pervasive bias against 
condoms and barrier methods, both by programs and the population, that prevails in many 
developing countries. 
 There are various obstacles to detection, or diagnosis, including a lack of standardized 
terminology and criteria.  For example, almost every study that we have reviewed here uses a 
different list of RTIs.  There is also a discouraging lack of correspondence between clinical and 
laboratory findings and intrinsic limits to client self-diagnosis.  There are difficult issues 
surrounding the management of asymptomatic cases, which relate in large part to the problems 
inherent in the development and use of appropriate, sensitive, and reliable behavioral risk 
screening methods.  The limitations of diagnostics technology come up again and again.  There is 
an additional aspect to this problem, which has not come up prominently in this meeting, but 
which has arisen in our research:  there is a certain pride and independence among clinicians, an 
attitude that they do not need to rely on technology, and that (true or not) they have become so 
experienced at recognizing signs and symptoms through clinical examination that it might be a 
retrograde step to become dependent on lab technology when the technology itself is so limited.  
Provider training, quality of care, and laboratory support present additional obstacles to effective 
diagnosis, as does strict quality control, which applies to all aspects of diagnosis. 
 Obstacles to RTI treatment include the relative effectiveness of targeting core transmitter 
groups versus mass interventions, involving issues of stigmatizing the core group versus the cost-
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effectiveness of this approach.  Antibiotic abuse and resistance are factors in many of the 
countries in which we work, as is the lack of a reliable drug supply for poorer segments of the 
population.  Providers also tend to resist partner notification and treatment; they are reluctant to 
get involved and feel that they are not trained in what needs to be done or in the necessary 
counseling approaches.  Training providers in counseling skills is extremely important.  Lack of 
confidentiality, which inhibits individuals from seeking treatment, is a problem in many developing 
country settings.  In Indonesia, for example, there is free HIV testing at a main teaching hospital, 
but most people do not want to attend as they feel that everyone will know if they test positively for 
the virus. 
 In the technical/biomedical area there seems to be a lack of consensus on key issues, 
including risk screening; antibiotic prophylaxis for intrauterine device (IUD) insertion; and the role 
of hygiene and its relationship to RTIs.  The development of low-cost diagnostics is also a key 
technical/ biomedical concern. 
 Finally, there are the programmatic obstacles.  Programs are often set up vertically, and 
there is a lack of coordination both within and between agencies.  If the family planning program is 
separate from the health department, this is even more problematic, as they often perceive 
themselves as having very different missions. 
 
Policy change 
 Openness, a general obstacle in this field, is particularly relevant with regard to policy 
change.  Communication is also important, whether between agencies or between government 
and non-governmental sectors and researchers and academics.  Donor/international community 
equivocation may also be a continuing problem.  Are our developing country colleagues still 
getting mixed signals from the international community and donors with regard to the importance 
of RTIs?  In some countries, I think this continues to be the case.  Finally, lack of research hinders 
policy change, bringing us full circle to the obstacles to the development and conduct of research 
presented above. 
 
Esther Muia 
The Population Council 
Nairobi, Kenya 
 
 
 In conducting research on sexually transmitted diseases (STDs) in Kenya, we 
encountered many of the obstacles discussed above.  The project aimed to strengthen STD/HIV 
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management.  In the past, there were special STD clinics in Kenya and people were reluctant to 
attend them due to the stigma involved.   When they were required to bring their partners with 
them, they would sometimes pay a stranger the equivalent of 50 cents to accompany them 
instead.  An additional problem related to the fact that many women did not have access to the 
clinics, regardless of their limitations, for financial or social reasons.   
 We attempted to find a way to improve services in this environment and, after much 
consideration, decided on an approach that would involve both communities and the clinics 
themselves.   
 The community approach involved a focus on special groups, including adolescents and 
prostitutes, who were given information on how to gain access to services and about the 
symptoms of STDs.  We also trained peer counselors to work with these special groups.   
 The clinic approach involved training more health care workers, including private 
practitioners, and obtaining more supplies and drugs.   
 We developed and employed a syndromic approach to STD management because 
existing lab facilities were not sufficient to enable us to test all clients.  In addition, we devised 
forms that aimed to reduce waiting time for partner diagnosis and treatment.   
 The main obstacles we faced related to personnel problems and lack of equipment— 
including gloves, syringes, and drugs.  Staff turnover was high, as providers felt that the project 
was requiring them to do more than they were originally hired to do.  We also lacked effective 
supervisors.  The socio-cultural obstacles related to the stigma attached to having or seeking 
treatment for an STD remained problematic.   
 We had tried to involve policymakers from the start, but it became clear that some of 
them had no idea what was going on.  Some simply came to meetings and asked questions, but 
did not seem to be interested in taking steps themselves.  When we approached policymakers to 
help pay for drugs to continue the project, many were reluctant.  Our success in involving 
policymakers, therefore, was uneven.  As noted above, we need to find ways to strengthen the 
link between researchers and policymakers so that when a research project is completed the 
community will continue to receive improved services.    
 On a positive note, the procedures we developed are being adopted by the Ministry of 
Health.  However, it will be a long time before they are implemented because the Ministry must 
secure funding for drugs.  Perhaps if we had made stronger ties with policymakers from the start, 
they could now be implemented more quickly.   
 
Nandini Oomman 
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Johns Hopkins University 
School of Hygiene and Public Health 
Baltimore, Maryland 
 
 
 I will present some of the obstacles we faced when we conducted our research on 
ethnomedical models of vaginal discharge in India, which I described in detail earlier. Qualitative 
and quantitative data collection was carried out in remote, desert villages in rural India, which 
posed three types of obstacles:   
 Logistics   Getting from one remote village to another was quite difficult.  Because the 
sites were so far away from each other, we had to live in villages for four days a week for four to 
five months in order to gather data and get to know the women.  We also had to set up clinics in 
schools and could not transport specimens to a hospital or university laboratory in time to make 
diagnoses.  As local staff were not available, an entire research team had to be transported to 
each site. 
 Socio-cultural issues   Women's and men's knowledge of their bodies was quite limited, 
and people were suspicious of gynecological examinations.  Because women view discharge as 
resulting from economic problems, they did not think that a physical examination could benefit 
them. 
 Ethics   It was not clear to us how we could, in this kind of environment, design a study to 
determine reproductive tract infection (RTI) prevalence rates or recruit a random sample of 
women.  In addition, the research itself would raise the public's consciousness in this area, before 
the data was used, and without any guarantee that related services would be provided.  Because 
the gynecological exam did not necessarily lead to treatment in women who felt they had, but 
were found not to have, a problem, some women felt ignored or mistreated.  Should such women 
be given placebos or gifts?   
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 DEFINING THE RANGE OF FUTURE RESEARCH PRIORITIES AND INTERVENTIONS 
 
Earmporn Thongkrajai 
Community Health Development Project 
Department of Medical and Surgical Nursing 
Khon Kaen University 
Khon Kaen, Thailand 
 
Following are some research priorities that have emerged during our discussions.   
 · Consensus has not yet been reached on the consequences and scope of reproductive 
tract infections (RTIs).  Although much research has been done on these topics, more 
is needed. 
 
 · RTI services need to be integrated with other health care services, including maternal 
and child health (MCH) programs, so that individuals who seek or need them do not 
feel stigmatized. 
 
 · We need to find ways to integrate RTI services with existing MCH and family planning 
(FP) services more smoothly.  At present, such efforts often result in health care 
providers becoming overloaded and in high staff turnover. 
 
 · We need to develop interventions that take into account the fact that RTIs are not only 
a medical problem, by looking closely at women's perceptions of their experiences, 
including discharge or other symptoms that may not fit into our biomedical model.  For 
many women, RTIs are simply symptoms they do not understand and rarely get a 
chance to talk about.  We also need to examine and work on the attitudes of health 
care providers in this regard.  When a woman seeks help for symptoms that the 
provider does not recognize, how does that make her feel?  What are the 
consequences? 
 
 · We must study the cultural factors that prevent women from talking about RTI-related 
symptoms or seeking help, and develop interview techniques that use appropriate 
questions to elicit this information.  
 
 · We need to know, on a context-specific basis, the types of traditional medicine that are 
used by women when they experience such symptoms as discharge or pain during 
urination. 
 
 · We must pay continued attention to the gender and empowerment issues related to RTI 
care and prevention.  In Thailand, for example, there are many cases of women who, 
after becoming informed about AIDS, ask their partners to use condoms and are then 
physically abused for making this request.  We need to help such women find effective 
and safe ways to negotiate with their partners.   
 
 · We need to continue to invest in the development of female-controlled technology.   
  
 · We need to conduct more research on RTIs and their relationship to AIDS. 
 
 · We must find ways to prolong the lives and improve the quality of life for those who are 
terminally ill with AIDS.  In Thailand, for example, we use meditation and some 
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traditional herbal medicine to improve the quality of life for women with AIDS.  
 
 
Adepeju Olukoya 
Women's Health Organization of Nigeria 
Lagos, Nigeria 
 
We need more research on social science topics, including:  
 · gender and power relations and the decisionmaking that occurs "behind closed doors" 
related to sexually transmitted diseases (STDs) and related protective measures; 
 
 · client acceptance of and attitude towards various types of service integration (family 
planning and RTI services, for example); 
 
 · health workers' perceptions of RTIs; and 
 
 · the relationship between personal hygiene and infection, including menstrual 
management and other practices that affect the genital tract. 
 
There is an urgent need for biomedical research on topics related to reproductive tract infections 
(RTIs), including:  
 
 · appropriate low-cost diagnostics and screening; and 
 
 · appropriate screening tools.  
 
Research on other interventions is also needed, including: 
 
 · community education; 
 
 · broadly defined case management; and   
 
 · training of health care workers, including "unorthodox" peer counselors and traditional 
birth attendants (TBAs). 
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 CLOSING SUMMARY 
 
Beverly Winikoff and Christopher Elias 
The Population Council 
New York, New York 
 
 In closing, we will review the group's responses to the informal questionnaire (see 
Appendix), which will, perhaps, articulate where we stand as a group in terms of our thinking on 
reproductive tract infections (RTIs). 
 
Importance of RTIs/STDs 
 There is a good deal of agreement that candida, bacterial vaginosis, and trichomonas are 
the most widespread infections, that they are relatively easy to deal with, and that they are not the 
most serious.  This is a perfect case study for education and debate on public health issues.  
What do you do when the infections that are easiest to treat pose the least serious health 
problems?  The group agreed that gonorrhea, chlamydia, syphilis, and human papilloma virus 
(HPV) are more serious infections, but more expensive to diagnose and treat, and more difficult to 
manage.  Among these infections, syphilis and gonorrhea are the easiest to treat.  There seems 
to be a great deal of frustration about our inability to provide appropriate services.  Few 
participants talked about human immunodeficiency virus (HIV).  Many focused on chlamydia, and 
many on low-cost diagnostics. 
 
Imagine you are a provider of IUD services.  What STD/RTI services must you provide in 
order to offer contraceptive services of an acceptable quality?    
 Thirteen participants responded that providers must be able to diagnose and treat RTIs in 
order to provide contraceptive services of an acceptable quality.  Four of these participants stated 
that providers must be able to treat all RTIs.  Ten respondents felt that providers must, at a 
minimum, be able to treat gonorrhea (GC) and chlamydia, and some of these respondents also 
stated that providers must also be able to diagnose and treat pelvic inflammatory disease (PID), 
bacterial vaginosis, and "common RTIs" in order to provide quality services.  Six participants 
stated that providers must provide risk screening by history or behavioral criteria, clinical selection, 
or self-screening.  Information, education, and communication (IEC), pelvic exams, Pap smears, 
and other "check-ups" were cited by one participant each.  An additional participant included a 
physical exam and cervical gram stain, and another indicated that the promotion of condom use 
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for clients with more than one partner was necessary.   
 
If you were providing family planning, but not the intrauterine device (IUD), would your 
answer be different from the one given to the question above? 
 Seven participants responded in the affirmative and stated that fewer RTI-related services 
would be needed to provide quality contraceptive services if the IUD were not offered.  Five 
participants said their answer would not change, and asserted that RTI diagnostic capacity must 
be available in either case.  Five participants said that the same level of service should be 
provided regardless of whether or not the IUD was offered, but noted that providers should only be 
responsible for performing clinical risk assessment if it was not.  One participant said that more 
services were needed if the IUD was not provided, including HPV, syphilis, and candida 
screening, and another noted that the answer to this question would depend, presumably on other 
factors related to RTI prevalence, and so forth. 
 
Which is the most important RTI problem to be addressed? 
 Most participants felt that chlamydia should be given priority.  Three participants said that 
the development of low-cost diagnostic techniques was most important, and two that enhancing 
awareness of RTIs, and IEC efforts, were most important.  Septic abortion was the fourth most 
commonly mentioned priority problem.  Training, problems related to vaginal discharge, sexual 
decisionmaking issues, syphilis, acceptable means of prevention, and PID were cited as the most 
important problem by one participant each.  
 
If you were torn when answering the above question and want to mention another 
important problem, what would it be?  
 Three participants cited issues related to HPV and cervical cancer, two cited gonorrhea, 
and prolapse, candida, PID, HIV, and low-cost diagnostics were cited by one participant each.  
One participant raised a more conceptual problem:  can we rely on risk assessment?  
 
Which is the most important service to provide? 
 Six participants stated that RTI diagnosis and treatment is the most important service, 
four cited counseling and information, three cited "screening" (although it is unclear whether this 
meant case finding or risk assessment), two cited primary prevention, and the empowerment of 
women and syphilis control were cited by one participant each. 
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Which is the second most important service to provide? 
 Treatment, Pap smears, prenatal syphilis screening, development of laboratory capacity, 
education, safe abortion, and screening were among the responses to this question.    
 Our discussions over the last two days have been lively, and we have heard a great deal 
that has made us reevaluate our thinking related to RTIs.  We have had the opportunity to talk 
about a very complex set of issues with a variety of people from diverse organizations.  More 
questions have been raised than conclusions reached.  Hopefully, we will be able to move forward 
in our efforts to answer these questions, which include: 
 
 
 1. How do we use the tools and information from the quantitative and qualitative research 
that has been conducted in both advocacy and program planning? 
 
 2. What do the results to date suggest about the approaches to service delivery that will 
be most fruitful? 
 
 3. How should we modify the direction and/or type of research that we are conducting on 
this topic? 
 
 Your continuing input on the third question will be of great use to us.  Our impression is 
that the Population Council's Robert H. Ebert Program needs to build on, and move beyond, its 
work in this area:  we have tended to focus on primarily descriptive studies and should move 
toward intervention studies that are more directly involved with service provision.  Other research 
priorities include:  examining health-seeking behavior related to RTIs; exploring ethnomedical 
models of the way providers diagnose infections; and standardizing diagnostic procedures. 
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 APPENDIX 
 Questionnaire 
Infection Prevalence Dx. Easy Dx. Cheap Rx. Easy Rx. Cheap Serious 
Candida       
B.V.       
Trichomonas       
Gonorrhea       
Chlamydia       
Syphilis       
HPV       
 
1. Using a scale from + for "a little" to ++++ for "a great deal," please rate each of these infections 
according to the 6 characteristics above. 
 
 
 
2.Imagine that you are a provider of IUD services.  What STD/RTI services do you need to provide in 
order to offer contraceptive services of acceptable quality? 
 
 
 
3.Would your answer to #2, above, be different if you provided contraceptive services, but not the IUD? 
 
 
 
4A. Which is the most important RTI problem to address? (Name one only) 
 
 
 
 B. Which is the most important RTI service to offer? (Name one only) 
 
 
 
5.If you had trouble naming only one problem or service, above, here is your chance to name another. 
(Complete only if you felt torn between choice.) 
 
 A. Another problem: 
 
 B. Another service: 
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